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This dissertation consists of a general introduction, a review of the literature, 
two separate manuscripts (PAPER I AND II), a general summary and discussion, 
literature cited, and acknowledgements. PAPER I has been published in the journal 
"Infection and Immunity" (Jonghwa Won and Ronald W. Griffith. 1993. vol. 61:2813-
2621) and is included in its entirety even though portions (Fig. 1 to Fig. 6) overlap with 
the candidate's M.S. thesis. In PAPER II, the mouse vaccination and challenge study 
was done in conjunction with Louise Henderson at the National Veterinary Services 
Laboratories. The references cited in each manuscript are listed in "LITERATURE 
CITED" at the end of each manuscript while the references cited in the rest of the 
dissertation are listed in the "LITERATURE CITED" at the end of the dissertation. 
Background 
Haemophilus somnus is a small, pleomorphic, gram-negative coccobacillus with 
unclear taxonomic status. H. somnus is an economically important pathogen that 
causes thromboembolic meningoencephalitis (TEME) (4, 5, 56, 66, 114), septicemia 
(84), respiratory disease (2,3,63,89,97), abortion (19,52,74,76,81,113) and weak 
calf syndrome (17,115,118) in cattle. Although it was first described as an etiologic 
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agent of TEME and septicemia, an increasing number of cases of respiratory disease 
associated with H. somnus have been reported in the last decade (71, 97). H. 
somnus is frequently isolated from respiratory (26, 27,46,97) and reproductive tracts 
(25, 49, 50) of healthy cattle. It is believed, at least in respiratory disease, that stress 
associated with shipping, weaning, ration changes and concurrent bacterial or viral 
infection increase the incidence of the disease and augment the transmission of the 
organism (27, 71). 
The interaction of H. somnus with the host humoral immune system is unclear. 
Bactericidal activities were observed in antiserum raised against H. somnus in the 
presence of complement and leukocytes in vitro, suggesting the importance of 
humoral immunity in protection (85). However, the ability of animals to resist infection 
after vaccination could not be predicted by serological tests (44, 97,104,107). Some 
researchers attempted to correlate serum antibody titers against H. somnus with an 
animal's susceptibility to disease, but the relationship between these two is difficult to 
determine (101,106). It was suggested that antibodies against nonprotective antigens 
might be present so that serological tests measuring these antibodies would give 
meaningless results (106). 
H. somnus bacterins have been widely used in cattle to stimulate immunity, but 
their efficacy is sometimes questioned (44, 46, 71, 72, 92, 97,107, 123). Vaccination 
with anionic antigens of H. somnus separated from more cationic antigens by anion-
exchange chromatography (at pH 6.0) provided protection against challenge with 
pneumonic or TEME strains of H. somnus (88, 104). No protection was provided by 
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cationic antigens (88, 104). Detrimental effects of lipopolysaccharide of id- somnus 
were also reported when it was administered with the anionic antigens (88). It was 
suggested that a subunit vaccine consisting of protective antigens might give more 
consistent protection against H. somnus disease. In the search for protective antigens 
of H. somnus. immunoreactivity of H. somnus antigens with convalescent-phase sera 
has been obsen/ed (21, 39, 40). Convalescent-phase serum from cows with H. 
somnus-induced experimental abortion recognized the 76- and 40-kDa antigens of H. 
somnus (21). Immunoreactivity to the 76- and 40-kDa antigens were observed with 
convalescent-phase serum from calves with experimentally-induced H. somnus 
pneumonia (40). Antibody against these antigens was correlated with protection 
against pneumonia (40), Further study indicated passive protection against 
experimentally- induced pneumonia with H. somnus by antibody against the 78-kDa 
antigen (39). 
In our studies we demonstrated that a 31-kDa protein of H. somnus seems to 
be of importance in the immune response of cattle. The 31-kDa antigen gene of H. 
somnus has been cloned, sequenced and characterized. And the potential of the 31-
kDa protein as a protective antigen was explored. An E. coli recombinant expressing 
the 31-kDa antigen was evaluated for its ability to stimulate a protective immune 
response in mice against virulent challenge with H. somnus. 
In addition to problems establishing a protective immune response, the 
diagnosis of diseases caused by H. somnus is frequently difficult due to the common 
use of antibiotics, the fastidious growth of the organism and overgrowth by other 
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bacteria (10, 23, 46, 117). Crossreactivities among H. somnus and other bacteria in 
various immunological tests also increase the difficulty of diagnosis (31, 78, 99). 
Immunoglobulin titers (22, 25,121) which complicate serological diagnosis may result 
from the presence of H. somnus in the respiratory and reproductive tracts of normal 
cattle. Herein we describe the use of the recombinant 31-kDa protein to generate 
monoclonal and polyclonal antibodies. These antibodies were tested in a variety of 
immunological assays for diagnostic use in H. somnus disease. 
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LITERATURE REVIEW 
History of Disease Occurrence 
Thromboembolic meningoencephalitis (TEME) was first observed in 36 cattle 
in Colorado in 1956 (43). Characteristic lesions were observed in the brain, but 
lesions were also frequently observed in the digestive, respiratory and cardiovascular 
systems. It was postulated that TEME occurred subsequent to septicemia resulting 
from a variety of primary infections. A wide range of gram-positive and gram-negative 
bacteria were recovered from lesions. However, the etiologic agent was not identified 
at that time (43). In 1960, Kennedy et al. recovered a small, gram-negative 
coccobacillus from the brain and other tissues of affected animals (56). This 
bacterium was classified as a Haemophilus-like organism based on morphological, 
cultural and biochemical characteristics (56). Bailie et al. reported isolation of an 
Actinobacillus actinoides-like organism from 25% of 78 sick cattle with TEME in 
Kansas (5). In a subsequent study. Bailie changed the name of the causative agent 
of TEME from A. actinoides-like bacterium to Haemophilus somnus (4). TEME was 
found to be the major encephalitic condition of cattle in Kansas, accounting for 60.5% 
of the cases in which a diagnosis of encephalitic disease was made (4). Many cases 
of this disease were observed in the USA (13, 18, 31, 73, 82, 84) and Canada (66, 
114). TEME was also diagnosed in Germany, Italy, Scotland, and Switzerland (96, 
105). 
The association of H, somnus with respiratory disease was not reported until 
the 1970's. H. somnus was isolated from lungs of suckler calves after sudden death 
in Scotland (89). Later, isolation of H. somnus from calves with pneumonia was 
reported from Australia (63), Northern Ireland (14) and North America (2, 3). In Iowa, 
H. somnus was isolated from 105 cases in cattle over a four-year period (1978-1982). 
A high percentage (87.6%) of those cases involved pneumonia (2). Saunders et al. 
also isolated H. somnus from 78 cases of bovine fibrinous pneumonia and pleuritis in 
Western Canada over a ten-year period (1969-1978). According to a report involving 
167 feedlot calves in Canada during 1979-1980, most deaths were attributed to 
pneumonia (63%), especially due to fibrinous pneumonia (45%) (71). Although 
Pasteurella haemolytica is considered to be the major cause of fibrinous pneumonia 
in cattle, a significant number of deaths were due to TEME. However, the overall 
percentage was low (14%) (71). 
Reproductive diseases associated with H. somnus infection are less well-
characterized than other diseases caused by this organism. Several reproductive 
diseases associated with a Haemophilus-like organism were reported without a 
thorough description of the diseases. Many of the early investigators were unable to 
identify their isolates. Miller et al. indicated in their review that organisms referred to 
as Haemophilus-like may or may not have been H. somnus (77). In 1959, Firehammer 
suggested a Haemophilus somnus-like organism as a possible contributor to bovine 
reproductive disease and abortion (36). The definite association of H, somnus with 
abortion in cattle was first reported in 1975 in the USA by Chladek (19) and in Canada 
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by van Dreumel and Kierstead (113). An abortion rate of 11.5% v/as observed in one 
herd (113). Since then, many reports of naturally occurring H. somnus infections and 
experimental challenge have provided evidence that H. somnus is involved in bovine 
abortion (52, 74, 76, 81). Other reproductive syndromes reported are weak calf 
syndrome (17, 115, 118), retained placenta (75) and repeat-breeder (RB) cow 
syndrome (60, 81, 83). However, association of H. somnus with the weak calf 
syndrome is still being debated (102). Waldhalm et al. observed higher isolation rates 
of H. somnus in cows with weak calves than cows with normal calves in the same 
herds (115). In a controlled study, H. somnus was inoculated into the uterus and the 
rate of occurrence of weak calves was compared with controls (115). Several weak 
calves were born from the treated group, while there were no affected calves in the 
control group. This difference was statistically significant (115). In another study, 
increased concentrations of anti-H. somnus immunoglobulins were observed in sera 
of newborn calves after H. somnus was inoculated in utero (51). However, since 
naturally occurring weak calves didn't have increased immunoglobulin concentrations 
in precolostral sera, they concluded that fetal infections with H. somnus were not 
involved in the weak calf syndrome (51). 
Classification 
The taxonomic status of Haemophilus somnus is still a subject of debate. A 
gram-negative coccobacillus implicated as an etiologic agent of TEME was initially 
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classified as a Haemophilus-like organism by Kennedy et al. (56). This taxonomic 
placement was based on the observation of biochemical, morphological and 
cultural characteristics (56). However, in their report, they indicated that growth of 
this Haemophilus-like organism was not dependent on X (hemin) or V factor (NAD) 
(56). Later reports confirmed that this organism does not require X or V factors for 
its growth (89, 99, 103). The requirement for X and/or V factor for growth is the 
primary criterion for inclusion in the genus Haemophilus. The International 
Committee of Systematic Bacteriology subcommittee recommended that the genus 
Haemophilus should be restricted to gram-negative rods or coccobacilli with a 
requirement for hemin or certain other porphyrins (factor X) and/or nicotinamide 
adenine dinucleotide (NAD; factor V) or other definable coenzyme-like substances 
(9, 57, 124). Although H. somnus does not fit the biochemical criteria of the genus 
Haemophilus, the name is still used because the proper genus has not been 
determined. Actinobacillus actinoides-like bacterium was suggested as a proper 
name (5), but later, Haemophilus somnus was suggested as a new species in the 
genus Haemophilus by the same author (4). The species name, "somnus", was 
chosen because one of the typical clinical signs of TEME caused by this organism 
was sleepiness (4). 
The mole percentages of guanine plus cytosine (mol %G+C) of the DNA of 
this organism was compared with that of other bacteria (6, 41). H. somnus had a 
mol %G+C of 37.3% (6), which is within 1% to 3% of the values obtained for H. 
influenzae (37.8%) (8) and H. parainfluenzae (39.0%) (67). Hybridization was 
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conducted to determine the degree of homology between DNA from H. somnus 
and other bacteria (41). Brenner proposed that two organisms are moderately 
related when 46-60% binding at 55°C or 3g-43% binding at 60°C occur between 
DNA from two organisms (12). JH. somnus was reported to be moderately related 
to H. influenzae. H. parainfluenzae and Actinobacillus lianieresii and not to be 
related to representatives of the genera Pasteurella. Escherichia, or Micrococcus 
(41) according to Brenner's criteria (12). In their study, higher DNA:DNA homology 
(58% at 60®C) was observed between H. influenzae and A. lianieresii than any 
other combination of H. influenzae and other species of Haemophilus tested (41). 
This lead them to suggest that the genus Haemophilus might be closely related to 
the genus Actinobacillus (41). In another DNA-DNA hybridization study, H. 
somnus. H. aani and Histophilus ovis were reported to be genetically related at the 
species level but not related to Actinobacillus seminis and a strain of JH. influenzae 
(116). One year later, it was confirmed that H. somnus. H. ovis and one of the H. 
aani strains studied represent one genetically homogeneous species (86). No 
genetic relationship was observed with other species of the genus Haemophilus. 
Actinobacillus. and Pasteurella in the same study (86). Stephens et al. observed 
similarities among H. somnus. H. aani and Histophilus ovis strains in their 
morphologic, biochemical and cultural characteristics and antigen profiles (103). 
They suggested inclusion of those three species into a Haemophilus-Histophilus 
(H-H) group. No similarities between any of those test strains and H. influenzae 
and A. lianieresii were noted (103). 
Serologic methods have also been used to relate H. somnus to known 
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genera. Shigidi and Hoerlein observed that rabbit antisera raised against various 
Haemophilus strains from cattle with thromboembolic meningoencephalitis in 
California and Colorado had high agglutinating titers to each other (99). This 
caused them to conclude that the bovine Haemophilus-like organisms were 
antigenically homogeneous (99). Garcia-Delgado et al. also indicated that there 
were no antigenic differences among H. somnus strains from Ontario, western 
Canada and the USA by agglutination, complement fixation, immunodiffusion and 
counterimmunoelectrophoresis tests (38). In 1982, Canto and Biberstein applied 
cross-adsorption-agglutination procedures to elucidate serological relationships 
among various H. somnus isolates of different pathological and geographical 
origins (15). They concluded that H. somnus isolates of Swiss and American 
origins were antigenically heterogeneous and could be divided into 4 groups (15). 
Crossreactivities were observed consistently with Haemophilus aani (16, 31, 78, 
99), frequently with P. multocida and P. haemolytica (16, 31), and less regularly 
with Brucella abortus. Bordetelia bronchiseptica. Listeria monocytogenes. 
Streptococcus agalactiae. Actinobacillus lianieresii and Campylobacter fetus (78, 
99). 
According to biochemical, cultural, and antigenic characteristics and DNA-
DNA hybridization studies, H. somnus seems to be most closely related to H. aani 
and Histophilus ovis (86, 103). H. aani was first isolated from sheep with 
septicemia (55), but subsequent isolations of this bacterium have not been 
reported. Histophilus ovis was originally isolated from the udder of a ewe with 
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mastitis in Australia (95). H. ovis was also associated with septicemia (91). Webb 
et al. reported the isolation of H. ovis from natural cases of epididymitis in rams, 
polyarthritis in lambs, mastitis and abortion in ewes (119). H. ovis was reported to 
be responsible for ovine septicemia, synovitis, epididymitis and vaginitis in Australia 
(20), New Zealand (54) and Canada (48). 
The species of veterinary importance in the genus Haemophilus are 
Haemophilus fActinobacillusl pleuropneumoniae. H. parasuis. H. paraaallinarum 
and H. aani (111). H. pleuropneumoniae was moved to the genus Actinobacillus 
(87) and is responsible for contagious pleuropneumonia in swine (98). This 
infection spreads rapidly under conditions of intensive husbandry, inclement 
weather, poor ventilation and infection by other respiratory pathogens (111). H. 
parasuis is present in the nasopharynx of many normal swine (100). In the 
presence of influenza virus and/or other stresses, it becomes highly pathogenic 
and causes influenza-like signs such as coughing, fever, inappetence, pneumonia 
and death (100). It also causes polyserositis in swine, known as "Glasser's 
disease" (94, 111). H. paraaallinarum causes "fowl coryza" that involves 
inflammation in turbinates, sinus epithelium and trachea, and air sacculitis (1). 
Diseases 
Haemophilus somnus infections of cattle can involve the nervous, 
respiratory, alimentary, renal, musculoskeletal and reproductive systems. This led 
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to the term "H. somnus complex" being applied to these diseases (13, 105). 
Thromboembolic meningoencephalitis is an acute septicemic disease of 
cattle caused by H. somnus. It is usually seen in feedlot cattle, one to three years 
of age (5, 56, 66, 114) in early winter (56). Occurrence of disease is sporadic and 
neurologic signs are variable (56). In its early stages, making animals move and 
careful inspection of them can aid in detection of clinical signs (56). Clinical signs 
include stiffness with knuckling at the fetlocks, reluctance to move, depression, 
ataxia, rectal temperatures up to 107® F (5, 56, 114). Appropriate antibiotic 
treatment works well at this stage (5, 56). At later stages, obvious signs of central 
nervous system disturbance, i.e., lateral recumbency, stupor, posterior weakness, 
involuntary paddling movement of the limbs (muscular tremors), opisthotonus, 
blindness and paralysis develop rapidly and often lead to death even with treatment 
(5, 56, 73, 114). Mortality rates vary from 1 to 95% (5). Affected brain tissue has 
focal or multifocal hemorrhagic necrotic foci in the meninges often extending into 
the gray and white matter (5, 56, 114). Lesions are characterized by bacterial 
vasculitis resulting in extensive thrombosis of meningeal veins and parenchymal 
capillaries with subsequent infarction (5, 56). There is an acute neutrophilic 
response (56, 114). 
Haemophilus somnus is also involved in the bovine shipping-fever-complex. 
Pulmonary infection results in bronchiolitis, bronchopneumonia and fibrinous 
pneumonia. Although H. somnus is frequently recovered from the upper-
respiratory tract of healthy cattle (26, 27, 46, 97), it can be a primary pathogen of 
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the respiratory tract under conditions of stress, e.g., shipping, cold weather. 
Calves also become carriers of H. somnus without showing any clinical illness (27). 
Mortality rates can also increase with the feeding of corn silage, mixing of cattle 
from different sources and vaccination against respiratory disease in the first month 
after arrival (71). Other bacterial and viral agents also can be predisposing factors. 
These include Pasteurella haemolytica. Pasteurella multocida. Mycoplasma spp., 
infectious bovine rhinotracheitis (IBR) virus, bovine respiratory syncytial virus 
(BRSV), parainfluenza type III (PI-3) virus and bovine viral diarrhea (BVD) virus. 
Respiratory diseases due to H. somnus usually occur in young calves, several 
weeks to six months of age (3, 63, 89, 97), most frequently during late fall to winter 
(2, 33, 89). Affected calves show depression, coughing, dyspnea, nasal discharge, 
hyperthermia, anorexia and pyrexia (2, 33, 63). Disease progresses rapidly, and 
sometimes leads to death. The gross appearance of infected lung includes gray to 
red-gray consolidation with white exudate in ainways (3) and emphysema (2). 
Microscopically, lung lesions include purulent to necrotic bronchiolitis, 
bronchopneumonia, fibrinous pneumonia, pleuritis and vasculitis (2, 3, 63). 
Bronchioles are often plugged by proteinaceous material including bacteria and 
inflammatory cells (2). In chronic lung lesions, necrosis and loss of bronchiolar 
epithelium, hyperplasia, peribronchiolar fibroplasia and bronchiolitis obliterans can 
be seen along with macrophages and giant cells (2). 
In some studies, H. somnus was found in the reproductive tracts of a 
majority of asymptomatic cattle (25, 49, 50). A lack of correlation between H. 
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somnus isolation and inflammatory lesions was reported (75). Reproductive 
disease associated with H. somnus include abortion, severe vulvitis, vaginitis, and 
endometritis (19, 60, 113). The association of H. somnus with the birth of weak 
calves (115) and infertility (60) is not clear. H. somnus was isolated from aborted 
fetal lung and placenta (19). Grossly, lesions in the placenta consisted of edema 
and necrosis of cotyledons. Microscopically, focal, hémorragie necrosis of the 
chorionic epithelium of the cotyledon (19) and cotyledonary placenta (113) was 
observed. Edema of the stroma with aggregating mononuclear cells, 
predominantly macrophages with a few neutrophils was also observed (113). 
Mixed infections with other pathogens were not characteristic of abortion (25). 
Diagnosis 
Identification of etiologic agents is generally accomplished by biochemical 
tests on recovered bacteria or immunological tests on serum or tissue fluids 
obtained from affected animals. Diagnosing diseases caused by H. somnus is 
frequently difficult due to the common use of antibiotics, the fastidious growth of 
the organism, and overgrowth of culture media by other bacteria (10, 23, 46, 117). 
Crossreactivities of H. somnus with other bacteria in various immunological tests 
also cause difficulties in diagnosis. Bacteria reported to have some 
crossreactivities to H. somnus are P. haemolvtica (122) and P. multocida (122), 
Brucella abortus (99) and Streptococcus aaalactiae (78). The presence of H. 
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somnus in the respiratory and reproductive tracts of asymptomatic cattle also 
complicates serological diagnosis due to possible serum immunoglobulin titers to 
H. somnus. Corbeil et al. indicated that nearly all cattle had positive agglutinating 
titers to H. somnus in the microagglutination test (MAT), based on serum samples 
submitted to the Washington Animal Disease Diagnostic Laboratory (WADDL) for 
respiratory or abortion serological screens in 1983 (25). In a study of experimental 
abortion, antibody titers to H. somnus measured by the MAT were high even 
before inoculation and increased less than two-fold (25). However, lgG2 titers 
increased 100-fold compared to other isotype titers which only increased 4-10 fold 
in ELISA (120, 121). The lgG2 titer was significantly higher in animals with H. 
somnus disease (pneumonia or abortion) than in clinically normal cattle (122). It 
was suggested that an lgG2 specific ELISA may be a useful diagnostic tool for H. 
somnus infection (25, 121, 122). 
One of the dependable biochemical test systems is the APIZYM 
microbiological identification system (APIZYM Analytab Products, Plainsview, NY) 
which measures various enzymatic activities (45). APIZYM system differentiates H. 
somnus from P. haemolytica. P. multocida and Bordetella bronchiseptica. 
However, H. somnus has similar enzyme activities to those of Histophilus ovis and 
Haemophilus aani. Although H. somnus isolates had variable reactions, they had 
identifiable patterns of enzyme activity. H. somnus isolated from different 
anatomical sites did not show different patterns of reaction except esterase-lipase 
activity. Isolates from cases of abortion/infertility had no esterase-lipase activity 
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compared to isolates from cases of encephalitis or pneumonia which had weak, 
inconsistent activities (45). 
Thromboembolic meningoencephalitis may easily be confused with CNS 
infection due to other bacteria. Herrick compared clinical signs, necropsy findings 
and cerebrospinal fluids and pointed out differences between TEME and listeriosis 
(47). It is also difficult to differentiate TEME from bovine polioencephalomalacia 
and acute lead poisoning. Little et al. indicated that differences in clinical features, 
gross pathologic lesions and the location and nature of CNS lesions might be 
helpful in diagnosis (65). Measuring levels of creatine phosphokinase (CPK) in 
serum was reported to be useful in diagnosis of central nervous system disorders 
(93). In contrast to most tissue enzymes, creatine phosphokinase is present in 
skeletal muscle, cardiac muscle and brain. Damage of tissues resulting in cell 
death or alteration of cell permeability would cause enzyme leakage and elevation 
of the CPK level in the serum. This could be used as an indicator of damage to 
either heart, skeletal muscle or brain. Since glutamic oxaloacetic transaminase 
(SGOT) is also present in skeletal muscle, it was suggested that a normal SGOT 
and an elevated CPK level in the bovine supports a diagnosis of brain degeneration 
(93). However, serum CPK levels of animals measured after H. somnus challenge 
didn't show any increase (79). The usefulness of measuring serum CPK levels to 
diagnose H. somnus disease has not been determined (79). 
It is difficult to determine the etiologic agent of respiratory disease by clinical 
signs and pathologie/histologie findings. The enzyme-linked immunosorbent 
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assay (ELISA) to measure levels of IgG in serum to H. somnus was proposed as a 
diagnostic method (68). According to a challenge study, the serum IgG titer 
developed faster with intratracheal inoculation of H. somnus than with intravenous 
inoculation (68). Although the ELISA had some cross-reactivities to P. haemolytica. 
the authors indicated that the cross-reactivity was not of such magnitude as to 
confuse P. haemolytica infection with H. somnus infection. However, the actual 
usefulness of this method in naturally infected cattle was not determined. Since 
polyclonal antibody against whole cells may result in crossreactivities (78), 
monoclonal antibody was generated to the 46-kDa protein, the major outer 
membrane protein of H. somnus (110). The coagglutination assay using 
monoclonal antibodies coupled with Cowan strain I Staphylococcus aureus protein 
A agglutinated ten different H. somnus isolates grown in vitro, while showing no 
agglutination with Actinobacillus suis. A. equuli. P. haemolytica. P. multocida and P. 
pneumotropica (110). 
The causes of abortion can be divided into noninfectious and infectious. 
Noninfectious causes of abortion include trauma, drug-induction, plant toxicity, and 
nutritional deficiencies/toxicities. The infectious agents cover a wide range of 
organisms from bacteria to viruses (30, 34). Bacterial agents include Brucella. 
Leptospira. Campylobacter. Haemophilus. Ureaplasma. and Chlamydia. Viral 
agents include infectious rhinotracheitis (IBR) virus, bovine viral diarrhea (BVD) 
virus, parainfluenza type III (PI-3) virus, bovine herpesvirus type 4 and bluetongue 
virus. Other agents include fungi and protozoa. Although the percentage of 
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abortions due to infectious agents has been estimated to be as high as 40 to 60% 
of the total (34, 58), only a low percentage (10-40%) of infectious cases were 
identified by laboratory diagnosis (30, 34, 59). The Washington Animal Disease 
Diagnostic Laboratory designed the abortion diagnosis kit after a prototype model 
from Cornell University which diagnoses bacterial abortions only. This abortion 
diagnosis kit applies a multi-diagnostic approach including bacteriology, virology, 
histopathology and serology. Serological methods determine antibody titers from 
the dam or fetus (34). The microagglutination test (MAT) of fetal fluids indicated 
that 34% of samples had seroreactivity to H. somnus (35). Although there was an 
82% correlation between the presence of serum titers and fetal immunoglobulins, 
the accuracy of this method to detect H. somnus infection was not clearly defined 
(35). Disadvantages of using the MAT are instability of the MAT antigen, 
crossreactivities between immunoglobulins to whole cell antigen preparations of H. 
somnus and a number of other gram-negative bacteria (78), and inability to assay 
a particular class of immunoglobulins (68). In a study of experimental abortion, 
Widders et al. also reported that the MAT titers were high before challenge but little 
increase occurred after challenge. They concluded that the MAT would not be 
useful for diagnosis (121). In the enzyme-linked immunosorbent assay (ELISA) 
large quantities of antigen can be prepared in a short period of time and they 
remain stable when stored frozen for at least 6 months without losing activity (68). 
Measuring IgM titers was indicated to be poor diagnostic method because high 
IgM titers were observed even before challenge and did not increase remarkably 
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after challenge. This was known to be a common finding for other gram-negative 
infections (22) as well as in H. somnus infections (121). The IgM response 
seemed to be a cross-reactive antibody to gram-negative outer membrane antigens 
(22). A remarkable increase and persistence in the lgG2 response was observed 
in the same experimental abortion study. There was a 100-fold increase in titer 
which persisted up to 30 weeks (121). The importance of the lgG2 response in 
diagnostic tests and protection has been suggested (121). 
Vaccination and its Efficacy 
Several Haemophilus somnus bacterins are available commercially but their 
ability to induce protective immune responses have been questioned. Although 
some have suggested that H. somnus bacterins are safe and protective (44, 46, 
92, 97, 107, 123), others did not find any benefit from vaccination (72) or found it 
could even be potentially harmful (71). Inconsistent protection has also been 
provided by vaccines against other bacterial respiratory pathogens (69, 70, 72). 
Evaluating the efficacy of vaccines for preventing respiratory diseases is difficult 
because other factors such as mixed infection, management, weather and ration 
also affect disease incidence and severity. The complex nature of respiratory 
disease results in highly variable morbidity and mortality rates among farms (72). 
The efficacy of H. somnus bacterins has been evaluated in field studies (46, 
71, 72, 97). Most of vaccinations were done with a commercially available killed 
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bacterin mixed in aluminum hydroxide adjuvant (Somnugen; Bio-Ceutic 
Laboratories, Inc., St. Joseph, MO) (46, 72, 97). Due to the sporadic nature of 
TEME, sometimes only a small number of control animals were affected and the 
resulting information was too incomplete to draw conclusions (97). Results from 
vaccination varied from protective to detrimental (46, 71, 72). Vaccination had no 
significant effect on treatment rates in one study (72). In another study, although 
the results were not statistically significant, it was indicated that vaccination with an 
H. somnus bacterin upon arrival at the feedlot might be detrimental (71). The 
detrimental effects were avoided by postponing vaccination until two days after 
arrival (71). Another study reported that immunization immediately upon arrival at 
the feedlot with a commercial H. somnus bacterin had no significant effect on the 
long-term mortality rate. However, during the first two months after entering the 
feedlot, vaccinated animals had reduced morbidity and mortality rates (92). In 
another study, vaccination reduced the carrier rate of H. somnus in nasal cavities 
about 6-fold compared to a nonvaccinated group (46). Also in the same study, 
clinical signs of encephalitic and respiratory diseases were only observed in some 
nonvaccinated groups. From these observations, the authors concluded that 
vaccination prevented H. somnus disease. However, Stephens et al. argued with 
this conclusion because the carrier rate fluctuated considerably over the period of 
the trial and there was no evidence suggesting that carrier status influences 
resistance to TEME (105). In addition, identification of causative pathogens by 
culture was not available due to antibiotic therapy after onset of disease (46). 
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Experimental challenge studies were also performed to evaluate the efficacy 
of id. somnus bacterins. Somnugen" was the most intensively studied bacterin (44, 
107,123). Intramuscular immunization protected cattle from intravenous, 
intracisternal or intrasubarachnoidal challenge, as indicated by a higher survival 
rate, reduced morbidity and less severe gross lesions (44, 107, 123). 
Stephens et al. suggested that frequent failure of vaccination may be 
attributed to infection with H. somnus serotypes not present in vaccine stocks 
(104). To identify H. somnus antigens responsible for inducing protective 
immunity, an anionic antigen was separated from the more cationic antigens by 
anion exchange chromatography (at pH 6.0) (104). Significant protection against 
intravenous challenge exposure was observed in cattle vaccinated with outer 
membrane complex (OMC) or anionic antigens of H. somnus (104). A semi-
purified outer membrane anionic antigen fraction of H. somnus also protected 
cattle against experimentally-induced pneumonia as determined by lower clinical 
scores and less extensive gross lung lesions (88). However, vaccination with 
anionic H. somnus antigens containing lipopolysaccharide from H. somnus resulted 
in harmful effects (88). 
Immunogenicity of H, somnus Bacterins 
Several serological tests including a double immunodiffusion assay, complement 
fixation test, bacterial agglutination test and ELISA have been used to determine 
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the immunogenicity of H. somnus bacterins. After vaccination, animals had 
increased serum antibody titers as measured by various serological tests (44, 46, 
97, 104, 107, 123). Another question was whether serological tests can be used to 
determine the immune status of animals after vaccination so that one can predict 
the level of protection against H. somnus diseases. A double immunodiffusion 
assay using a soluble antigen derived from H. somnus was suggested to be useful 
in evaluating the immune status of animals after vaccination (46, 123). All calves 
with sera producing two or more precipitin bands were immune, whereas those 
with sera eliciting less than two precipitin bands were generally susceptable to 
intracisternal challenge of H. somnus (123). However, Stephens et al. reported that 
there were no cattle which gave positive reactions in the double immunodiffusion 
test after vaccination (107), although the same test method was used as reported 
previously (46, 123). Using the complement fixation test (CFQ, higher 
seroconversion rates were observed in vaccinated animals compared to 
unvaccinated animals (97, 107). However, protection of animals from H. somnus 
diseases couldn't be predicted by serum antibody titers measured by CFT (97, 
107). No significant changes in antibody titers were observed in the bacterial 
agglutination test after vaccination (44, 107). Anionic-antigens of H. somnus (at pH 
6.0) were reported to endow protection against H. somnus challenge (104). But 
high immunoglobulin (Ig) G and IgM titers in ELISA against anionic-antigens were 
also observed in animals that had died of H. somnus disease (104). However, an 
antibody response consisting of both IgGI and lgG2 occurred in cattle vaccinated 
23 
with anionic-antigens, while a lower lgG2 response was observed in animals 
vaccinated with anionic-antigens plus LPS from H. somnus. This indicated that the 
LPS of H. somnus had detrimental effects (88). In another study, vaccinated 
animals had higher titers in solid-phase immunoassay and less severe clinical signs 
compared to non-vaccinated animals (44). 
Humoral Immune Response to H. somnus 
In vitro bactericidal activities of bovine sera against H. somnus have been 
observed in animals immunized with either sonicate, whole cell or protein 
preparations of H. somnus in the presence of leukocytes and complement (85). In 
another study, sera from adult cattle had significantly higher bactericidal activities 
and agglutinating antibody titers than those of yearlings and 4- to 5-month-old 
calves (101). It is during this time that animals are most susceptible to H. somnus 
infection. This bactericidal activity was complement dependent but the 
concentration of bactericidal antibody appeared to be the limiting factor (101), 
which agrees with an earlier report (85). Although the possible protective role of 
antiserum was suggested (85, 101), serum agglutinating antibody titers did not 
correlate with the animals's susceptibility to H. somnus infection in another report 
(106). All cattle that died had a mean 4-fold increase in agglutination titer during 
the acute phase of disease after challenge (106). It was suggested that 
contradictory reports about the importance of the humoral immune response in 
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protection might be attributed to detection of nonprotective antibodies. This led to 
comparison of isotypic antibody responses. The incidence of other respiratory 
diseases was inversely correlated to the serum IgG level of animals (29). The 
serum and nasal lgG1, lgG2 and IgA levels of calves were lowest between 2 and 4 
weeks of age during which the onset of pneumonia was highest (24). As lgG2 
concentrations increased, fewer calves developed pneumonia (24). In experimental 
abortion with H. somnus. prechallenge antibody titers were measured using a 
microagglutination test and an isotype specific ELISA (121). Animals which calved 
normally had higher prechallenge lgG2 antibody titers to H. somnus and their lgG2 
titers increased remarkably after challenge and persisted a long period of time 
(121). This led the authors to suggest the lgG2 response was important in 
protection against H. somnus diseases (121). After challenging cattle with H. 
somnus. convalescent sera from recovered animals were used in Western blots to 
determine possible protective antigens (21). Convalescent bovine sera from cattle 
with H. somnus-induced abortion recognized 76K and 40K antigens, which were 
conserved in H. somnus isolates from animals with TEME, pneumonia and 
reproductive failure as well as isolates from asymptomatic carriers (21). 
Convalescent serum from calves with H. somnus pneumonia strongly reacted with 
78K and 40K antigens (40). The passive protective ability of these convalescent 
sera were also suggested when H. somnus was incubated with either preimmune 
or convalescent serum before intrabronchial inoculation. No pneumonia developed 
in animals inoculated with bacteria that had been previously incubated with 
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convalescent serum (40). In a later study, 78K and 40K outer membrane proteins 
(OMP) were purified and used to raise antibodies (39). Preincubation of H. 
somnus with antibody against the 40K OMP protected calves from H. somnus 
induced pneumonia, wliile antibody against the 78K OMP did not (39). This failure 
of protection by antibody against 78K OMP was suggested to be due to lack of 
Induction of an lgG2 response (39). 
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PAPER I. CLONING AND SEQUENCING OF THE GENE ENCODING A 31-
KILODALTON ANTIGEN OF HAEMOPHILUS SOMNUS 
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ABSTRACT 
Immunoblots using bovine antibody against Haemophilus somnus as the 
primary antibody consistently identified 31-, 40- and 78-kilodalton proteins in 
sarkosyl-insoluble extracts of H. somnus. A genomic library of H. somnus 8025 
DNA was constructed In plasmid pUC19, and 45 recombinants expressed proteins 
which were recognized by bovine antiserum in Western blots. Ten of the 
recombinants expressing a 31-kDa protein caused the lysis of bovine red blood 
cells. Restriction endonuclease mapping indicated that the hemolytic recombinants 
shared an approximately 1.7-kilobase Bglll fragment. Southern blot analysis using 
the Balll fragment as a probe revealed homology among the recombinants and the 
presence of an identically-sized Bglll fragment in the chromosome of all H. somnus 
isolates tested. Sequence analysis indicated the presence of an 822-bp open 
reading frame within the 1.7-kb Bglll fragment. Deletion of this ORF resulted in the 
loss of hemolytic activity and protein expression in recombinant E. coli, suggesting 
the possible role of the 31-kDa protein as a hemolysin. An amino acid sequence 
deduced from the DNA sequence shared homology with outer membrane protein A 
of E. coli, Salmonella typhimurium and Shigella dysenteriae. with P6 of 
Haemophilus influenzae and with Pill of Neisseria gonorrhoeae. An amino acid 
analysis of the recombinant 31-kDa protein agreed with the deduced amino acid 
composition from the DNA sequence. 
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INTRODUCTION 
Haemophilus somnus is a small, pleomorphic, gram-negative coccobacillus 
with unclear taxonomic status. It was first described as the cause of 
thromboembolic meningoencephalitis (TEME), a serious disease of cattle 
characterized by incoordination, depression, thrombosis, and necrotizing vasculitis 
(18, 24). The organism was later confirmed to cause other cattle diseases 
including pneumonia (1, 2), abortion (23, 25), infertility (25) and septicemia (37). 
The mechanism of interaction of H. somnus with the host humoral immune 
system is unclear. Bactericidal activities were observed in antiserum raised against 
whole cells, sonicate, or protein antigens of H. somnus in the presence of 
complement or complement and leukocytes in vitro (39). In one study, low 
bactericidal activities of sera against H. somnus were observed in the most 
susceptible age groups (47). However, another study reported loss of cattle with 
high agglutinating antibody titers in experimental challenge with a TEME isolate of 
H. somnus (50). H. somnus bacterins have been widely used in cattle to stimulate 
immunity but their efficacy is sometimes questioned (32, 45). 
In the search for protective antigens of H. somnus. either challenge studies or 
analysis of the immunoreactivity of H. somnus antigens to convalescent sera have 
been employed. Saline-extracted, outer-membrane-complex and anionic antigens 
of H. somnus protected cattle from H. somnus challenge after two vaccinations 
(49). Anionic antigens also protected cattle from a virulent pneumonic strain of JH. 
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somnus (40). However, administration of anionic antigens combined with 
lipopoiysaccharide interfered with protection, as measured by higher clinical and 
histopathological scores (40). Convalescent serum from cows with H. somnus-
induced experimental abortion recognized 76- and 40-kDa antigens of H. somnus 
(10). Protective ability and immunoreactivity to 78- and 40-kDa antigens were 
observed with convalescent serum from calves with experimentally-induced H. 
somnus pneumonia (15). Further study indicated passive protection against 
experimentally-induced pneumonia with H. somnus by antibody against the 40-kDa 
antigen (16). Failure of antiserum against the 78-kDa antigen to provide protection 
was considered to be due to the lack of lgG2 (16), which was suggested to be 
important in protection against H. somnus infection (55, 56). 
Preliminary work in our laboratory indicated that proteins in addition to the 40-
and 78-kDa may be involved in the immune response against H. somnus. A 
genomic library of H. somnus was generated in E. coli DHSa and screened for 
immunoreactive clones. Because H. somnus has been described as producing a 
hemolysin (14, 22), we also screened the genomic library for hemolytic clones. 
Herein, we describe the cloning, sequencing and characterization of the gene 
encoding a 31-kDa protein of H. somnus. 
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MATERIALS AND METHODS 
Bacteria and Growth Conditions 
Sources of bacterial strains used in this study are described in Table 1. 
Haemophilus somnus 8025 was stored in sterile egg yolk at -80°C. Initial growth 
from storage was on 10% bovine blood agar (Difco Laboratories, Detroit, Ml) at 
37°C in 5% COj for 24 h. For large batch culture, several colonies were 
transferred to 10 ml of brain-heart infusion broth (Difco) containing 5% newborn 
calf serum (Gibco Laboratories, Grand Island, NY) and 0.5% yeast extract (Difco) 
(BHISY) and grown for 7-8 h. This log phase culture was transferred to 500-1000 
ml of BHISY medium and grown for 8-12 h with sparged aeration (5% COg in air). 
Escherichia coli DH5ff, hemolytic E. goji and Pasteurella haemolvtica were grown in 
brain-heart infusion broth with agitation (200 rpm). Actinobacillus 
pleuropneumoniae was grown in brain-heart Infusion broth containing NAD (40 
//g/ml; Sigma Chemical Co., St. Louis, MO) for 3-5 h with agitation (200 rpm) at 
37 °C. Moraxella bovis was grown on 10% blood agar and washed from the plates 
with sterile Tris-EDTA-Saline buffer (0.05 M NaCI, 0.005 M EDTA [Disodium], 0.03 
M Tris [pH 8.0]). E. coli DH5a recombinants expressing immunoreactive proteins 
were grown on LB agar containing ampicillin (100)t/g/ml) for plasmid isolation and 




Bacterial strains used in this study. 
Strain Source" 
Actinobacillus pleuropneumoniae 
ATCC 1 P7 R. F. Ross, VMRI 
Pasteurella haemolytica 
L101 G. Frank, NADC 
Moraxella bovis 
62 LP12 R. Rosenbusch, VMRI 
Escherichia coli 
T191 J, Kinyon, ISU 
7118 J. Mayfield, ISU 
DH5a C. Thoen, ISU 







156-83 J. J. Andrews, ISU 




0620 I I  
m677 I I  
" Abbreviations: VMRI, Veterinary Medicine Research Institute; NADC, National 
Animal Disease Center; ISU, Iowa State University. 
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Antigen Preparation 
Outer membrane protein-enriched preparations of H. somnus were prepared 
by a modification of the method of Barenkamp et al. (3). Briefly, bacteria were 
harvested by centrifugation at 3,500 xg for 20 min at 4°C and 1.5 g (wet weight) of 
cells were resuspended in 20 ml N-2 hydroxyethyl-piperazine-N'-2-ethanesulfonic 
acid (HEPES [10 mM, pH7.4]). The protease inhibitor phenylmethyl sulfonylfluoride 
(Sigma) was added to a final concentration of 0.1 mM. Cells were disrupted by 
sonication (Model 350; Branson Sonic Power Co., Danbury, CT) for 10, one minute 
bursts (50% cycle, power setting 7) while cooling in an ice water bath. Cell debris 
was removed by centrifugation at 4,500 xg for 20 min. The supernatant was 
centrifuged for 1 h at 100,000 xg at 4°C and the pellet was resuspended and 
incubated for 30 min at room temperature in an equal volume of 2% sodium lauryl 
sarcosinate (International Biotechnologies, Inc., New Haven, CT) in 10 mM HEPES. 
The detergent-insoluble fraction was harvested by centrifugation at 100,000 xg for 1 
h at 4°C and resuspended in deionized water. The protein concentration was 
determined by bicinchoninic acid assay (Pierce Chemical Company, Rockford, IL). 
Aliquots were stored at -80 "C. 
Construction of the Genomic Library of H. somnus 
Plasmid pUC19 was isolated from E. goli 7118 (nonhemolytic). Chromosomal 
DNA was extracted by the procedure of Hull et al. (21). Chromosomal DNA of H. 
33 
somnus 8025 was partially digested with Sau3AI and size fractionated on a 10-40% 
sucrose gradient in 1 M NaCI-20 mM Tris (pH 8.0)-5 mM EDTA by centrifugation in 
a Beckman SW 27 rotor (100,000 xg) for 21 h at 10°C. DNA in the range of 5-10 
kb was ligated to pUC19 which had been cut with BamHI and treated with calf 
intestinal alkaline phosphatase (Boehringer Mannheim Biochemicals, Indianapolis, 
IN). Plasmid pUC19 containing H. somnus inserts was transformed into competent 
E. soli DHSff according to the standard transformation protocol of Hanahan (19). 
Plasmid DNA from hemolytic recombinants was extracted by the method of 
Birnboim and Doly (5). Restriction endonucleases (Bethesda Research 
Laboratories, Gaithersburg, MD) were used according to the manufacturer's 
instructions. 
Southern Blot Analysis 
Chromosomal DNA from hemolytic pathogens and H. somnus isolates, and 
recombinant plasmid DNA were digested to completion with Bgill and separated by 
electrophoresis on 0.75% agarose gel. DNA was transferred to nitrocellulose 
(Schleicher and Schuell Inc., Keene, NH) or nylon membrane (Hybond N, 
Amersham Corp., Arlington Heights, IL) by the method of Southern (48). The 
membrane was prehybrldlzed at 42 "C for 2-4 h followed by 24 h hybridization with 
the biotinylated probe at 42 °C (43). After hybridization, the nitrocellulose or nylon 
membrane was washed twice sequentially in the following solutions; 2X SSC (0.3 M 
NaCI, 0.03 M Na citrate, pH 7.0)-0.1% SDS for 2 min, 0.2X SSC-0.1% SDS for 2 
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min at room temperature and 0.16X SSC-0.1% SDS for 15 min at 50 °C, and briefly 
rinsed in 2X SSC-0.1% SDS at room temperature. The membrane was blotted in 
TBS (0.05 M Tris-0.2 M NaCI, pH 7.5) containing 3% bovine serum albumin and 
probed with streptavidin-alkaline phosphatase conjugate (1:1000)(BRL). After 
washing in TBS, reactive DNA was visualized by incubating in 0.1 M Tris-0.1 M 
NaCI-50 mM MgClj (pH 9.5) containing 0.4% nitroblue tetrazolium chloride and 
0.3% 5-bromo-4-chloro-3-indolylphosphate (BRL). For the probe, the 1.7-kb Balll 
fragment separated on 1% agarose gel was purified by electroelution in dialysis 
tubing with molecular mass cutoff of 12-14,000 (Baxter Diagnostics Inc., McGaw 
Park, IL.) at 80-100 mA for 3-5 h (43). After precipitation, purified DNA was 
conjugated with photoactivable-biotin (Clontech Laboratories Inc., Palo Alto, CA). 
Antisera 
Rabbit antisera prepared against formalin-killed H. somnus 8025 were used 
to identify immunoreactive clones in colony blotting. Bovine antisera were provided 
by Dr. John Andrews, Iowa State University Veterinary Diagnostic Laboratory, 
Ames, Iowa. These antisera were generated by inoculating cattle with either live H. 
somnus strain 156-83, a commercial bacterin, or an experimental bacterin. Calves 
were bled before and after immunization. Unless otherwise stated, all antibody was 
absorbed three times against live E. goli DHSa (pUC19) at 37''C. The same 
procedure was applied for serum absorption against H. somnus. 
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Colony Blotting 
Transformed bacterial colonies were transferred directly from agar plates 
onto dry nitrocellulose filters and lysed as described by Meyer et al. (33). Blotting 
was done by the modified procedure of Hawkes et al. (20). Briefly, filters were 
incubated with rabbit antiserum against H. somnus (diluted 1:400) at 37°C for 1 h, 
washed and incubated with biotinylated goat anti-rabbit IgG (BRL, diluted 1:2000) 
for 45 min at room temperature. The filters were washed and incubated with 
streptavidin-alkaline phosphatase conjugate (BRL) diluted 1:6000. Immunoreactive 
transformants were visualized with 0.44% nitroblue tetrazolium chloride (BRL) and 
0.33% 5-bromo-4-chloro-3-indolylphosphate (BRL). 
SDS-PAGE Analysis 
A modified Laemmli (28) procedure was used to separate proteins on 
discontinuous gels consisting of 4% stacking gels and 6-20% gradient or 14% 
resolving gels. Proteins with apparent molecular masses ranging from 14-200 kDa 
(BRL) were used as molecular mass standards. Bacteria were boiled in SDS gel-
loading buffer according to the procedure of Sambrook, et al. (43). After 
electrophoresis, proteins were stained with 0.1% coomassie blue R250 (43), For 




Nitrocellulose sheets were blocked in TBST (TBS containing 0.1% Tween 20) 
containing 3% gelatin for 1 h at 37°C and incubated for 2 h at 37° C with bovine 
antiserum against live H. somnus diluted 1:100 in TBST containing 1% gelatin. The 
nitrocellulose sheets were incubated for 45 min with peroxidase-conjugated goat 
anti-bovine IgG (Kirkegaard and Perry Laboratories, Inc., Gaithersburg, MD) diluted 
1:500 in TBST containing 1% gelatin. Bound IgG was visualized in TBS containing 
0.05% 1-chloro-4-naphtol (Sigma), 16% methanol and 0.08% hydrogen peroxide 
(Sigma). 
Subcloning of the 1.7-kb Bglll Fragment and Generation of Deletion Clones 
Belli fragments purified by gel electroelution as described above were ligated 
into BamHI-digested and calf intestinal alkaline phosphatase-treated pUC19. E. çoli 
DH5a were transformed and hemolytic recombinants were selected as described 
above. All recombinants containing a 1.7-kb Bglll fragment were hemolytic. One 
of these clones, S4, was used to generate deletion clones by using Exolll nuclease 
digestion as described by Sambrook et al. (43). After gradual deletion with Exolll, 
plasmids of various sizes were ligated, transformed into competent E. çoli DH5ff 
cells (BRL) and screened by growing on LB agar containing ampicillin (100 ug/ml). 
Approximate insert sizes were determined by comparing EcoRI-digested plasmid 
DNA of deletion clones with HinDIII-digested lambda DNA (BRL) on 0.75% agarose 
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gel and by sequencing data. Deletion clones were stored in 40% glycerol at 
-80 "C. 
DNA Sequencing 
Sequence analysis of the 1.7-kb Bglll fragment was performed by DNA facility 
(ISU, Ames, lA) according to the dideoxy chain termination method of Sanger et al. 
(44). Plasmid DNA from subclones and deletion clones were purified by using 
Qiagen columns as indicated by the manufacturer (Qiagen, Inc., Chatsworth, CA). 
Sequencing was carried out by using Taq DNA polymerase (Perkin Elmer Corp., 
Nonwalk, CT) and the sequencing kit (Applied Biosystems, inc., Foster City, CA) 
and read by sequence reader (model 373A; ABI), Primers for DNA synthesis were 
the universal and reverse primer (ABI). 
The DNA sequence and deduced amino acid sequence were analyzed using 
the GCG Sequence Analysis software package (Genetics Computer Group, Inc., 
Madison, Wl) (11). The Protein Information Resource and the Swiss Protein 
Source were searched for proteins that share homology with the deduced amino 
acid sequence of the 31-kDa protein of H. somnus 8025 using the FASTA program 
(38). 
38 
Amino Acid Analysis and Sequencing 
Sample preparation and following amino acid analysis and sequencing was 
done as described by Leyh (29). Briefly, the sarkosyl-soluble membrane protein-
enriched preparation from recombinant HSI109 was separated on SDS-PAGE (SO-
SO ug/lane) and transferred to a polyvinylidene difluoride (PVDF) membrane 
(Immobilon; Millipore Corp., Bedford, MA.) in 10 mM CAPS (3-[cyclohexylamino]-1-
propanesulfonic acid) (Sigma) transfer buffer (pH 11,0) containing 10% methanol at 
600 mA for 2 h. 
Amino acid analysis and sequencing was performed by the Iowa State 
University Protein Facility (ISU, Ames, lA). The band containing the 31-kDa antigen 
was excised and the protein was directly hydrolyzed on the PVDF membrane in 6 
N HCI at 150°C for 1 h under vacuum, A derivatizer (model 420A; ABI), a reverse 
phase C-18 silica high-performance liquid chromatography column (model 130A; 
ABI) and a data system (model 920A; ABI) were used for amino acid analysis, A 
peptide sequencer (model 477A; ABI) and amino acid analyzer (model 120A; ABI) 
were used to determine amino-terminal amino acids. 
Nucleotide Sequence Accession Number 
The GenBank accession number for the 1730-bp nucleotide sequence 
discussed below (see Fig, 8) is L07795, 
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RESULTS 
Immunoblot Analysis of H. somnus Antigens 
Eight bovine antisera against H. somnus TEME isolate (156-83) consistently 
detected 31-, 40- and 78 kDa antigens in sarkosyl-insoluble membrane fractions 
(data not shown). The 31-kDa antigen reacted weakly or not at all with pre-
immunization sera. Other proteins were detected but the reactions observed were 
not consistent. 
Construction of Genomic Library of H. somnus and Immunoblot Analysis 
Recombinant plasmids containing genomic DNA of H. somnus were 
transformed into E. coli DH5a. About 20,000 transformants were screened by 
colony blot using rabbit anti-H. somnus antibody. Immunoreactive recombinants 
were subjected to SDS-PAGE followed by immunoblot with bovine antisera. Forty-
five recombinants expressed proteins ranging in size from 18 to 200 kDa (some of 
them are shown in Fig.1). Some recombinant proteins including the 31-kDa protein 
(Fig. 1, lane D) comigrated with major H. somnus protein bands (Fig. 1). 
Expression of the 31-kDa protein was not dependent upon induction with IPTG. To 
help determine if the recombinant protein was folded similar to the native protein, 
antisera against H. somnus was absorbed with whole cell H. somnus. Reactivity to 
FIG. 1. Immunoblots of immunoreactive recombinants. Whole cells of H. somnus 
(A), recombinants (B-l) and E. coli DH5a (pUC19) (J) were separated on 
6-20 % gradient SDS-PAGE, transferred to nitrocellulose and probed with 
bovine antisera raised against H. somnus. Except for a cross reactive 
protein around 40 kDa, E. coli had no reactivity to bovine serum. 
Recombinants expressed immunoreactive proteins comigrating with H. 
somnus antigens in addition to the cross reactive protein. Eleven 
recombinants produced a 31-kDa antigen (lane D). Molecular masses are 
indicated in kilodaltons. 




both the native and recombinant 31-kDa proteins was eliminated or markedly 
reduced (Fig. 2). 
Hemolytic Activity of Recombinants 
The Immunoreactive recombinants were streaked on 10% bovine blood agar 
plates to evaluate their hemolytic activity. Ten recombinants were found that 
produced a distinct zone of complete hemolysis around colonies after one or two 
days of incubation at 37°C, All ten were found to encode an approximately 31-kDa 
protein. Only one recombinant (HSI94) producing a protein of this approximate 
size was nonhemolytic. 
Restriction Endonuclease Analysis 
Plasmids from representative recombinants (HSI38, HSI42, HSI109 and 
HSU 21) were compared by restriction endonuclease fragment analysis. The 
plasmids shared an approximately 2-kb fragment which included a 1.7-kb Balll 
fragment (Fig. 3). Inserts of pHSIIOQ and pHSI121 were in opposite orientation to 
those of pHSI38 and pHSI42. One recombinant plasmid (pHSI38) lacked a small 
portion of the Bglll fragment, but this appeared not to affect hemolytic activity. The 
plasmid from the non-hemolytic recombinant, pHSI94, had one Bglll site and no 
HinDIII site. The 31-kDa protein expressed by this recombinant was a fusion 
FIG. 2. Immunoblots of whole cells of H. somnus 8025 and a representative 
immunoreactive recombinant, HSI109. H. somnus 8025 and HSI109 were 
separated on 6-20% gradient SDS-PAGE, transferred onto nitrocellulose. 
H. somnus 8025 was probed with bovine anti-H. somnus serum before 
(A) and after (B) being absorbed against H. somnus. The recombinants 
were probed with bovine anti-H. somnus serum before (C) and after (D) 
absorption with H. somnus. Absorption of bovine antiserum against H. 
somnus removed or decreased the reactivity to the 31-kDa protein of 
both H. somnus (B) and HSI109 (D). An asterisk indicates a 31-kDa 
antigen. 





FIG. 3. Restriction endonuclease fragment maps of representative recombinant 
plasmids from clones expressing the 31-kDa protein. The dashed vertical 
lines extending through all maps provide a vertical register for the Bglll 
sites that represent the known, widest breadth of shared digestion sites 
for recombinant plasmids. The bars above the horizontal bars represent 
the location of restriction sites. B, Bglll; E, EcoRI: H, HinDIII: Sm, Smal: 
Xb, Xbal: Xh, Xhol. Restriction sites in the vector are indicated in italics. 
The inserted DNA is indicated as the solid black line. The vector is shown 
by hatched rectangle, in which hatch direction indicates the relative 
direction of vector to insert. In pHSI109 and pHSI121, DNA is inserted in 
opposite orientation to those of pHSISS and pHSI42. Plasmid pHSI94 
lacks the 5-prime portion of Bglll fragment. Regions extended by arrows 
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protein and was immunoreactive. A restriction map of pHSI94 relative to others 
was confirmed by Southern blot analysis. 
Southern Blotting of Inserts and Genomic DNA 
Strong reactivities to the 1.7-kb Bglll probe were observed with plasmids of 
all hemolytic recombinants, some of which are shown in Fig. 4. Because of the 
low stringency conditions, slight crossreactivity with pUC19 was noted. After 
digestion with Bglll, plasmid pHSI38 had a 6.4-kb reactive fragment, whereas 
others (pHSI42, pHSI72) had the 1.7-kb reactive fragment. This agrees with the 
restriction map (Fig. 3), in which pHSISS lacks one Bglll site. Plasmids from 
recombinants expressing antigens with other molecular masses did not react with 
the probe. The approximate location of pHSI94 insert relative to other inserts in the 
restriction map was confirmed by reactivity to two types of probes, 1.7-kb BglW 
fragment and 2-kb Xhol-Balll fragment (Fig. 3). Plasmid pHSI94 (non-hemolytic) 
reacted only with the Bglll probe while plasmids of hemolytic clones HSI38, 109 
and 121 reacted with both probes (data not shown). This and the results of the 
restriction endonuclease digestion indicates that pHSI94 has a portion of the BglW 
fragment but lacks the 5-prime ends including the HinDIII site. Genomic DNA of 
other H. somnus isolates as well as H. somnus 8025 contained a 1.7-kb Bglll 
fragment which hybridized strongly with the probe (Fig. 5). However, no reactivity 
was found with genomic DNA from other hemolytic pathogens including 
FIG. 4. Southern blot analysis of Bglll-digested recombinant DNA. A. Agarose 
gel stained with ethidium bromide. 1. Unlabeled 1.7 kb Bglll fragment. 2-
4. Plasmid DNA of hemolytic recombinants HSI38 (2), HSI42 (3) and 
HSI72 (4). 5. Nonhemolytic recombinant expressing a protein with 
different molecular mass. 6. Plasmid pUC19. B. Southern blot of A. The 
above fragments were transferred to nitrocellulose and probed with a 
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Fig. 5. Soutliern blot of genomic DNA from different isolates of H. somnus. A. 
1.7-kb Bglll fragment of recombinant HSI121, B-H: H. somnus isolates; B 
(m677), C (156-83), D (0620), E (9754B), F (21790), G (21778A), H 
(8025). Genomic DNA digested with Bglll were separated on 0.75% 
agarose, transferred to nitrocellulose and probed with photobiotin-labeled 
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A. pleuropneumoniae. M- bovis. hemolytic E. çoli (T191), and P. haemolvtica (Fig. 
6). 
Deletion Mutation and Sequence Analysis 
To determine the size and localize the position of the 31-kDa antigen gene, a 
1.7-kb Bglll fragment was subcloned Into plasmid pUC19 and a series of deletion 
clones were generated. Subclones containing an intact Bglll fragment expressed 
the 31-kDa protein and were hemolytic. The 3'-deletion caused a gradual decrease 
in size of the 31-kDa protein (Fig. 7, Table 2), All 3'-end deletions which contained 
at least 753 bp were hemolytic (Table 2). Deletion clone D27 and D33 lost 
immunoreactivity although it still retained hemolytic activity. Recombinant HSI94 
which did not possess 620 bp of the 5' end of the Bglll fragment was not hemolytic 
although it contained the rest of the Bglll fragment. Immunoreactivity was present 
in deletion clones having 1228 bp as well as in recombinant HSI94 (Table 2). 
The Bglll fragment was 1730 bp long, as determined by sequence analysis 
(Fig. 8). Consistent with restriction mapping, there was a HinDIII site 302 bp from 
the 5-prime end of the Bglll fragment. There were two open reading frames (ORF); 
however, one having only the 3'-portion (1-303) of the ORF lacked a termination 
sequence. Presence of this ORF didn't prevent deletion clones from losing 31-kDa 
antigen expression as well as hemolytic activity and immunoreactivity. Deletion of 
an ORF located from 487 to 1308 caused loss of both protein expression and 
Fig. 6. Comparison of H. somnus with other pathogens for reactivity to Balll 
probe on Southern blot. All genomic DNA were digested with Bglll. A. 
Agarose gel stained with ethidium bromide. Genomic DNA of H. somnus 
(1), Pasteurella haemolytica (2), hemolytic E. coli (3), Actinobacillus 
pleuropneumoniae (4) and E. coli DH5a (5). B. Southern blot of DNA 









Fig. 7. SDS-PAGE analysis for protein expression of liemoiytic recombinants 
HSI121 (A), HSI109 (B), nonhemolytic recombinant HSI94 (C), E. coli 
DH5a (pUC19) (D), subclone S4 (E) and deletion clones, D6 (F), D14 (G), 
D24 (H), D23 (I), D15 (J). D6 expressed intact 31-kDa protein, while other 
deletion clones, D14 and D24, produced truncated proteins. 
Corresponding 31-kDa antigens in deletion clones are indicated by 
asterisks. E. coli DH5a (pUC19) didn't show any corresponding 31-kDa 
protein. 
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Table 2. Approximate endpoints of insert and phenotypes in deletion clones and 
recombinants. 
Recombinants Approx. positions of Hemolysis Immunoreactivity' 
5' 3' 
S4 1 1730 + + 
D6 1 1539 + + 
D41 1 1468 + ND 
D14 1 1228 + + 
D33 1 1118 + -
D27 1 753 + -
D56 1 676 - ND 
D23 1 446 - -
D15 1 347 - -
D17 1 297 - -
HSI94 820 >1730 - + 
' Immunoreactivity of the 31-kDa protein with convalescent bovine antisera on 
Western blot. 
® Not determined 
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hemolytic activity. This open reading frame was preceded by a potential Shine-
Delgarno region (AGG) which is located 10 bp upstream (477-479) from the 
presumed translation initiation codon (ATG). A palindrome, which might be a 
terminator, was located 18 bp downstream from the translation stop codon. 
An amino acid sequence was deduced from the ORF and compared with 
those of other proteins. The carboxy terminal end (134-249) of the sequence 
possessed homology with C-terminal amino acids of outer membrane protein A 
(OmpA) of E. soli (215-336; 41%), Salmonella tvphimurium (219-340; 41.8%) and 
Shigella dysenteriae (220-341 ; 41%), and a similar region of the 31-kDa protein 
(133-254) also had 25.6% homology with outer membrane protein III (Pill) of 
Neisseria gonorrhoeae (90-214). A portion of the 31-kDa protein (140-220) sharing 
35.4% homology with outer membrane protein P6 (P6) of H. influenzae (51-132) 
was within the C-terminal region (134-249) mentioned above. There was no 
significant homology between the 31-kDa protein and other hemolysins. 
Amino Acid Analysis and Sequencing 
Amino acid analysis data agreed well with that of the deduced amino acid 
sequence from the ORF located from 487 to 1308. However, no sequence data of 
amino-terminal amino acids were recovered because the 31-kDa protein of 
recombinant HSI109 appears to be N-terminal blocked. 
Fig. 8. Nucleotide sequence of the 1.7-kilobase Bglll fragment and its predicted 
amino acid sequences. An open reading frame, assumed to encode the 
31-kDa protein, is 822 base pairs long (487-1308). The solid underline 
indicates a putative Shine-Dalgarno region and the two arrows 




181 GTGCTTTCGGTAAAAT ATATGATGAAAAAATCACTCATTCAAAAATTAGGC AAACAAGCAGAAG AAAGTGCTAATAATGTGTTGTTACGA 
271 TTGCTGAAACGTGATG AG AGTACTTTG ATATAAGCTTACTCAACATTGCCC AAAAAGAGATTAAAATTTGGTTTACATTTTTGTTGTTTG 
361 ATATTAATATCTCAAGCAGTGCTGACGTGATTTAATGCGACAATATTTTTGTAAAGATAT AAAATTAAATCGTAAGCr ATTCAAAAAATT 
4SI TGAAGAAATTTATATACATAAAATTAAGGTAAAATAATGAAACTATCACGTTTTGTATTATCTGCTGTTGTAGCAGCAACATTGTCGGCT 
M K L S R F V L S A V V A A T L S A  
541 TGTGGTAATTTAAGT AATGTCACCGAAC AGGGTACATCAGATAACTTG AAGTGGCCTAAAATTG ATCAGTCAAGATTTAATC ATGATGGT 
C G N L S N V T E Q G T S D N L K W P K I D Q S R F N H D G  
631 AGCCAATTTGGATCGTGGCCAAACTGGGATAACCTACGTATGGTTGAACGCGGAATGAATAAAGATCAACTGTATAACCTATTGGGACGT 
S O F G S W P N W D N L R M V E R G M N K D Q L Ï N L L G R  
721 CCGCATTTTTCGGAAGGTTTATATGGTGTTCGTGAGTGGGACTATGCTTTTAATTATCGTGAGAATGGTGAGCATAAAATTTGCCAATAC 
P H F S E G L Y G V R E W D Y A F N Y R E N G E H K I C Q Y  
811 AAAATTTTATTCGATAAAAATATGAATGCCCAAAATrrCTATTGGTTTCCAAATGGTTGTAACGGTTATGCATCTTTTAGTTTAAATACG 
K I L F D K N M N A Q N F Ï W F P N G C N G Y A S F S L N T  
901 GATCTCTTATTTGATTTTGATCAAGATACGTTGACCTCAAAAGGTGAAGAAGCTGTTGATAATGTTGCAATGCAATTAGAAGCATTTTCA 
D L L F D F D Q D T L T S K G E E A V D N V A M Q L E A F S  
991 GCCAAAGAAATTAAAATTGTTGGTTTTACXGATCGATTGGGTACAGATTCTTATAACTTGGATCTTTCTCAACGCCGAGCTGATCGTGTT 
A K E I K I V G F T D R L G T D S Y N L D L S Q R R A D R V  
1081 SAAGAGCGTrTAATTGAAAAAGGGTTAAATATTGATATTATCGCTATTGGATATGGTAAAACGCAAC AGATTAAGGCTTGCAATGATGTA 
K E R L I E K G L N I D I I A I G Y G K T Q Q X K A C N D V  
1171 CCAGCCAAAGAACTAAAAGATTGCTTACGTCCAAACCGTCGTGTTGAAATTTCAGCATACGGAAACATCTCAAAAAAATATGGTAATGGT 
P A K E L K . D C L R P N R R V E I S A Y G N I S K K Y G N G  
1261 GAGCTGAAGGGGGGTACAACTGGTCCATCATTATATTACGAAAAATAATCTCTCTTGATATAGGTAAGGGCATCAAACGATGCCCTTTAT 
E L K G G T T G P S L Y Y E K »  '  '  
1351 TTATAGAATTATTTATCACTTTTGTGCAAAATTTGATTAATCAATTTCTGAGTGAGAGAAACATAACTTTGCTTTTTATTATAATAGCGA 






The 31-kDa protein of H. somnus is a possible candidate for a protective 
antigen because it showed strong immunoreactivity to convalescent bovine antisera 
against H. somnus. To predict its behavior and function, we cloned, characterized 
and sequenced the gene encoding the 31-kDa antigen. 
We have been unable to purify sufficient quantities of the 31-kDa protein in 
active form to determine if the protein is truly a hemolysin. The observed 
hemolysis could be merely the result of overexpression of a foreign protein in E. 
coli. Some H. somnus isolates are reported to cause complete lysis on blood agar 
(14, 22) while the majority of isolates produce incomplete lysis. The 31-kDa antigen 
caused complete hemolysis when expressed in E. coli although H. somnus 8025 
from which the 31-kDa antigen gene originated produced incomplete hemolysis. 
According to Southern blot, the 31-kDa antigen gene is present in a single copy in 
H. somnus 8025 and the apparent discrepancy may be due to higher expression in 
the recombinants. There have been no reports about the possible association of 
hemolytic activity and virulence in H. somnus. Whether the 31-kDa protein is highly 
expressed in vivo and causes increased virulence is not known. In addition to 
possible hemolytic activity, the 31-kDa antigen might express cytotoxic or inhibitory 
effects on cells of the immune system as do some hemolysins (26, 27, 41). The 
cytotoxic effect of H. somnus on bovine alveolar macrophages and bovine 
endothelial cells has been reported, although the responsible factor(s) was 
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unidentified (31, 52). 
Restriction mapping revealed that expression and intensity of hemolytic 
activity was not affected by the orientation of the insert in the vector, indicating the 
cloned gene of the hemolytic factor was dependent on its own promoter for its 
expression. A corresponding open reading frame (ORF) encoding a 31-kDa 
protein within the 1.7-kb Bgill fragment was determined by searching for a region 
whose deletion abrogated hemolytic activity and immunoreactive protein 
expression. The molecular mass of the protein decreased and hemolytic activity 
was eliminated by gradual loss of an ORF located from 487 to 1308. The 
calculated molecular mass (31.16 kDa) of amino acids deduced from this ORF 
agreed with the measured molecular mass (31 kDa) of immunoreactive proteins on 
SDS-PAGE gel. Amino acid analysis data also confirmed that this ORF encodes 
the 31-kDa antigen. Hemolytic activity was associated with the amino terminal end 
of the protein. A division of functional domains is illustrated by deletion clones D27 
and D33 which lost immunoreactivity while retaining hemolytic activity. On the 
other hand, recombinant HSI94 which lacks some of the amino terminal amino 
acids is not hemolytic but retains immunoreactivity. 
Diagnosis of disease caused by H. somnus is complicated by serological 
diversity among H. somnus isolates (8) and crossreactivity of H. somnus with other 
bacteria (9, 46). It is also difficult to isolate the organism because of overgrowth by 
other bacteria as well as prior antibiotic treatment in most cattle with respiratory 
disease. Serological tests including agglutination, complement fixation and 
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hemagglutination have crossreactivities with a broad range of bacteria (9, 46). 
However, relatively high specificity was observed in ELISA when a soluble antigen 
of H. somnus was used (9). A coagglutination test with monoclonal antibody 
against the 46-kDa band of H. somnus differentiated H. somnus from Actinobacillus 
suis. A. equuli. P. haemolytica. P. multocida (53). Since strong reactivity to 
relatively small amounts of 31-kDa antigen was observed with antiserum against H. 
somnus on immunoblot, monoclonal antibody against 31-kDa antigen might give 
additional specificity in an ELISA. Detection of H. somnus in tissue sections would 
be very useful because of difficulties in recovering the organism on culture. 
Detection in tissues might be simplified by using DNA probes. Tests using DNA 
probes have many advantages. They do not require specific antigen expression, 
the presence of large numbers of bacteria, or pure cultures (51). Use of a portion 
of a virulence gene (34), or of a restriction fragment of chromosomal DNA (12) as 
a diagnostic probe has worked well with other pathogenic bacteria. The 1.7-kb 
probe may be useful as a diagnostic probe because it discriminated H. somnus 
from other pathogens such as P. haemolytica. A. pleuropneumoniae. hemolytic E. 
coll and M- bovis. The absence of homology between the hly gene of A. 
pleuropneumoniae and genomic DNA of H. somnus has been reported previously 
(30). 
An amino acid sequence deduced from the 822-bp-ORF was compared with 
that of other proteins. Carboxy terminal ends of the deduced amino acid sequence 
had homology with C-terminal ends of a variety of proteins, including the 
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periplasmic portion of outer membrane protein (OmpA) in E. coli (4, 7), g. 
dysenteriae (6) and g. typhimurium (13), P6 of Haemophilus influenzae (36) and 
Pill in N. gonorrhoeae (17). The homologous region between Pill of N. 
gonorrhoeae and OmpA of E. cqN which were reported previously (17) includes the 
region of homology with the 31-kDa protein of H. somnus. The contribution of E. 
coll OmpA and Pill in N. gonorrhoeae to pathogenicity has been proposed (42, 
54). Also the protective role of antibody against P6 to H. influenzae has been 
proposed (35). However, whether this homology indicates functional importance or 
structural similarity is unclear. 
The location of the 31-kDa protein in the bacterial cell wall has not been 
identified. The portion of OmpA homologous with the 31-kDa protein is located in 
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PAPER II. PROTECTIVE AND IMMUNOGENIC CHARACTERISTICS OF THE 31-
KILODALTON ANTIGEN OF HAEMOPHILUS SOMNUS AND THE USE 
OF THIS PROTEIN IN DIAGNOSTIC TESTS 
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ABSTRACT 
The ability of the recombinant 31-kDa antigen of Haemophilus somnus to 
induce a protective immune response in mice was evaluated. Mice were 
immunized two to three times with a heat-killed E. soli recombinant expressing the 
31-kDa antigen of H. somnus and subsequently challenged with H. somnus strain 
156A. Significant protection was provided by the recombinant vaccine compared 
to E. soli with the vector plasmid only. Monoclonal and polyclonal antibodies were 
generated and their usefulness in detecting H. somnus and/or its 31-kDa antigen 
were determined. Monoclonal mouse antibodies were generated against a crude 
membrane fraction or a formalin-killed, whole cell preparation of the recombinant 
HSI109 producing the 31-kDa antigen of H. somnus. The monoclonal antibodies 
reacted strongly in an ELISA using a Triton-X 100-extract or a formalin-killed, whole 
cell preparation of H. somnus as an antigen. The monoclonal antibodies also gave 
a strong reaction in Western blots against the 31-kDa protein. However they did 
not detect H. somnus on immunohistochemical staining of formalin-fixed lung tissue 
sections from cattle that were culture positive for H. somnus. The lack of reactivity 
on immunohisto-chemical staining was not improved by prior treatment of lung 
sections with either glycine phosphate buffer or Triton X-100. Guinea pigs were 
immunized with the recombinant HSI109 killed by either heating at 70°C for 1 hour, 
UV-irradiation, or formalin. Aluminum hydroxide was used as an adjuvant. 
Additional Guinea pigs were immunized with formalin-killed whole cell H. somnus 
! 
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also adjuvanted with aluminum hydroxide. Sera from the Guinea pigs were 
analysed on ELISA, Western blot and immunohistochemical staining. Those sera 
reacted variably on ELISA. On Western blot, antisera directed against a UV-killed 
recombinant reacted most strongly to the 31-kDa antigen of H. somnus. However, 
only antisera produced against the heat-killed recombinant and formalin-killed, 
whole-cell H. somnus detected the organism in lung tissue sections. Possible 
crossreactivity was observed in the immunohistochemical stain with Pasteurella 
haemolytica and Pasteurella multocida. 
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INTRODUCTION 
Haemophilus somnus is a bovine pathogen which causes thromboembolic 
meningoencephalitis (14, 19), septicemia (24), respiratory disease (25), abortion (5) 
and weak calf syndrome (33). H. somnus is one of the major bacterial agents of 
respiratory disease in cattle in North America (1, 2) and Canada (21). Many 
healthy cattle have H. somnus in their respiratory (8, 9, 16) and reproductive tracts 
(17, 18). Similar to the situation observed with Pasteurella haemolytica and P. 
multocida. outbreaks of respiratory disease caused by H. somnus seem to be 
related to such stresses as shipping, inclement weather and concurrent bacterial 
and viral infections (1, 11, 21, 25). 
Protection afforded by commercial bacterins has been somewhat inconsistent. 
Although most studies suggest commercial bacterins are protective (15, 16, 30), 
there are also reports revealing a lack of protection (22) and even detrimental 
effects of commercial bacterins (21). lgG2 is thought to play a major role in 
protection against respiratory disease caused by H. somnus (36). The ability of 
immunogens to induce lgG2 production has been implicated as one possible factor 
in providing protection (13, 35, 36). Detrimental effects of the lipopolysaccharide of 
H. somnus in subunit vaccine were reported and this was suggested as a possible 
reason for failure of whole cell bacterins (26). In a previous report, a genomic 
library of H. somnus was generated in E. coli (37). Consistent immunoreactivity 
was observed between the 31-kDa antigen of H. somnus and sera from cattle 
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recovered from H. somnus challenge infections (37). In the work described here, 
mice were vaccinated with a heat-killed, aluminum hydroxide-adjuvanted E. coN 
recombinant producing the 31-kDa protein. The mice were challenged by an 
intraperitoneal route to evaluate the ability of the recombinant expressing the 31-
kDa antigen of H. somnus to induce a protective immune response. 
Diagnosis of H. somnus infection by bacteriologic culture and subsequent 
biochemical characterization is frequently hampered by treatment of cattle with 
antibiotics and overgrowth of culture media by other bacteria (3, 34). 
immunological detection methods have also had problems due to crossreactivity 
with other bacteria (10, 23, 29, 35). Crossreactivities were observed in several 
serologic tests including agglutination, immunodiffusion and complement fixation 
tests . High serum antibody titers against H. somnus in a majority of healthy cattle 
also make it difficult to differentiate infected cattle from healthy cattle (7). In this 
study we describe the generation of mouse monoclonal antibody and Guinea pig 
polyclonal antibody against H. somnus and various preparations of the 
recombinant expressing the 31-kDa H. somnus protein. The use of these 
antibodies in diagnostic applications was evaluated. 
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MATERIALS AND METHODS 
Immunization of Mice with Recombinant 31-kDa Antigen 
The E. coli recombinant HSI109 expressing the 31-l<Da antigen of Haemophilus 
somnus and E. goli DH5ff(pUC19) were grown in LB broth with ampicillin (100 
ug/ml) at 37°C for 24 h, followed by heat-inactivation at 70°C for 2 h. Heat-
inactivated bacterial cultures used for immunization were diluted to 2.5x10® CFU/ml 
in phosphate buffered saline (PBS, 0.15M PBS-0.85% NaCI). All bacterial 
preparations used for Immunization were freshly made within 2 days of vaccination. 
Bacterins were given (0.2 ml) to mice intraperitoneally, 2 to 3 times at 2-week 
intervals. 
Mouse Challenge 
For challenge, H. somnus strain 156A which was originally isolated from a case 
of bovine respiratory disease, was grown on Columbia agar containing 10% bovine 
blood. After 24 h incubation the cells were washed from the plate with LB broth 
and diluted to an absorbance of 0.6 at 540 nm on a Spectronic 20 (Bausch and 
Loomb) in LB broth. Serial 10 fold dilutions (0.1 ml) of the bacterial suspension 
were mixed with 0.9 ml of 7% mucin. The bacteria-mucin mixtures were inoculated 
intraperitoneally into mice 2 weeks after final vaccination. Control mice were 
injected with 7% mucin only. Mortality rates were recorded for 7 days post 
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challenge. A lethal dose was calculated based on the Reed-Muench method (27). 
A relative potency is the relative ability of one vaccine to provide protection to 
vaccinated animals compared with another vaccine or control group. The relative 
potency of the E. coH vaccine expressing the 31-kDa antigen versus E. coli with 
vector only was calculated by dividing the LDgo of H. somnus in the group of 
animals immunized with E. goli containing the vector only by the LDgo of H. somnus 
in group of animals immunized with the E. coli recombinant expressing the 31-kDa 
antigen of H. somnus. 
Generation of Monoclonal Antibodies 
Mice were immunized with either crude membrane fractions containing the 31-
kDa recombinant protein or formalin-killed recombinants. Aluminum hydroxide 
(Intergen, Purchase, NY) was used as an adjuvant at a final concentration of 0.4%. 
Immunization schedules and doses are indicated in Table 1. Three days before 
cell fusion, mice were given a booster dose of the appropriate antigens without 
aluminum hydroxide (Table 1). Cell fusion was done according to the procedure of 
Van Deusen (31). Hybridomas from mice immunized with the membrane fraction 
were screened by Western blot using H. somnus as an antigen, Hybridomas from 
mice immunized with the formalin-killed recombinant were screened by ELISA using 
formalin-killed H. somnus as an antigen. Hybridomas positive on screening tests 
were cloned by limiting dilution (6) and rescreened. To generate ascites fluids 
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Table 1. Immunization of mice for tfie generation of monoclonal antibodies. 
Type of immunogen Weeks Dose Adjuvant 
Membrane fraction 0 45 //g Yes 
3 22.5 //g Yes 
6 22.5 //g No 
Formalin-killed recombinant 0 1x10® CFU Yes 
3 5x10' CPU Yes 
5 5x10' CPU Yes 
7 1x10' CPU No 
10 6x10' CPU No 
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containing monoclonal antibodies, mice were primed with 0.5 ml of pristane (2, 6, 
10, 14-tetramethylpentadecane) (Aldrich Chemical Company, Inc., Milwaukee, Wl) 
intraperitoneally. Three weeks after priming, mice were inoculated intraperitoneally 
with 1x10° hybridoma cells which were washed and resuspended in PBS (6). 
Ascites fluids were drawn with a myelography needle (Becton-Dickinson, 
Rutherford, NJ), centrifuged, and stored at -80"C. 
Generation of Polyclonal Antiserum in Guinea Pigs 
Antigens used for immunization were prepared by four different methods. The 
preparations used were: 1. Formalin-killed H. somnus. 2. Formalin-killed 
recombinant HSI109, 3. UV-killed HSI109 and 4. Heat-killed HSI109. H. somnus 
was grown on 10% blood agar for 24-48 h, washed with PBS, mixed with formalin 
at the final concentration of 0.5% and incubated at 37°C overnight. An E. coli 
recombinant was grown in LB broth containing ampicillin (100//g/ml) until it 
reached optical density of 0.6 at 600 nm. The recombinant was killed with formalin 
by the same method as above. For UV-irradiation, 50-60 ml of the recombinant 
culture (ODgoo=0.6) was spread evenly over the bottom of a sterile 140-mm petri 
dish and irradiated with 3.6x10"* erg of UV light per mm^ For heat killing, bacteria 
were washed with PBS and heated at 70''C for 2 h. After confirming that all the 
bacteria were killed, bacteria were centrifuged, washed, resuspended in PBS at the 
proper dilution and stored at -80°C. Guinea pigs were immunized with the 
equivalent of 5x10® CFU of the proper immunogen and an identical booster dose 
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was given after 4 weeks. Three weeks after the second immunization, Guinea pigs 
were immunized with the equivalent of 1x10® CPU. All immunogens were mixed 
with aluminum hydroxide. Guinea pigs were bled by heart puncture 10-14 days 
after the last immunization and the serum was separated by centrifugation and 
stored at -20 ®C. 
ELISA 
As antigens, either Triton X-100 exract or formalin-killed whole cell H. somnus 
were prepared. For the preparation of Triton X-100 extract of H. somnus. H. 
somnus 156A was grown at 37°C in 10% COg. Bacteria were washed in PBS, 
resuspended and incubated in 0.1% Triton X-100 in Tris-tricine-EDTA buffer (pH 
8.6) for 18 h at 4°G. The preparation was filter sterilized (.22 //m) and stored at -
80 °C until use. For the preparation of formalin-killed whole cells, H. somnus 156A 
was grown by the same method as above, washed in PBS and incubated with 
formalin at the final concentration of 0.5% for 2 days. Aliquots were centrifuged 
and the pellet was stored at -80 °C until use. 
Microtiter plates (Immulon 1, Dynatech Laboratories, Inc., Chantilly, Virginia) 
were coated with 100 //I/well of antigen in 0.05M carbonate buffer (pH 9.6) and 
incubated for 1 h at 37° C, followed by 18 h incubation at 4°C. For washing and 
diluting, PBS-Tween (0.15M PBS-0,05M Tween 20) was used. For blocking, 1% 
BSA in PBS-Tween was used. Hybridoma culture supernatants (without dilution) or 
dilutions of polyclonal antisera were used as a primary antibody. Peroxidase-
labeled anti-mouse or anti-Guinea pig antibodies (1:2000) were used as a 
secondary antibody (Kirkegaard and Perry Laboratories, Inc. (kpl), Gaithersburg, 
MD). ABTS substrate (kpl) was added and the reaction was read at OD40B. 
SDS-PAGE Analysis 
A modified Laemmli (20) procedure was used to separate proteins on 
discontinuous gels consisting of 4% stacking gels and 14% resolving gels. 
Proteins with apparent molecular masses ranging from 14-200 kDa (BRL) were 
used as molecular mass standards. Bacteria were boiled in SDS gel-loading buffer 
according to the procedure of Sambrook, et al. After electrophoresis, proteins 
were stained with 0.1% coomassie blue R250. For immunoblotting, antigens were 
transferred to a nitrocellulose filter immediately after SDS-PAGE. 
Western Blot 
Nitrocellulose sheets were blocked in TBST (0.05M Tris-0.2M NaCI (pH 7,5) 
containing 0.1% Tween 20) containing 3% gelatin for 1 h at 37°C and incubated for 
2 h at 37® C with hybridoma culture supernatant (no dilution) or ascites fluids or 
polyclonal serum diluted in TBST containing 1% gelatin. The nitrocellulose sheets 
were incubated for 45 min with peroxidase-conjugated goat anti-mouse IgG or anti-
Guinea pig IgG (Kpl) diluted 1:500 in TBST containing 1% gelatin. Bound IgG was 
visualized in TBS containing 0.05% 1-chloro-4-naphtol (Sigma), 16% methanol and 
0.08% hydrogen peroxide (Sigma). 
Immunohistochemical Staining 
Formalin-fixed lung tissue sections were routinely processed (28), embedded in 
paraffin and cut at 0.5 //m on a microtome (AO Spencer rotary microtome model 
820, American Optical Corp., Buffalo, N.Y.). Sections were dried in a 80®C oven 
and deparaffinized by two 15 min changes of pro par clearant (Anatech, LTD., 
Battle Creek, Ml). After rehydration, endogenous peroxidase activity was removed 
by incubation with 3% hydrogen peroxide (two times for 20 min each). This was 
followed by two washes with Cadenza buffer (Shandon, Pittsburgh, PA). Tissue 
slides were attached to coverplates (Shandon) and assembled in reagent trays 
(Shandon). For use as primary antibodies, polyclonal sera and ascites fluids were 
diluted in Cadenza buffer. Hybridoma cell culture supernatant containing 
monoclonal antibodies were used without dilution. Blocking solutions, secondary 
antibody solutions and peroxidase-conjugated strepavidin (DAKO LSAB 2 Kit; 
DAKO Co., Carpinteria, CA) and (Vectastain ABC kit, Vector Laboratories, Inc., 
Burlingame, CA) were used with procedures modified from those of the 
manufacturer. Reagents from different sources were used for testing mouse 
(DAKO LSAB 2 kit) and Guinea pig (Vectastain ABC kit) antibodies. Briefly, tissue 
sections were blocked for 20 min, followed by overnight incubation with primary 
antibodies at 4°C. Tissue sections were incubated with biotin-labeled secondary 
antibodies for 20 min and incubated with peroxidase-labeled strepavidin for another 
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20 min. Each step except the blocking step was followed by washing with 
Cadenza buffer. The immunoreaction was developed by 3-5 min incubation with a 
colorizing reagent kit, 3,3'-diaminobenzidine tetrahydrochloride (DAB) substrate as 
recommended by the manufacturer (Zymed Lab. Inc., San Francisco, CA), followed 
by washing with distilled water. Tissue sections were briefly counterstained with 
Mayer's hematoxylin and washed with tap water. 
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RESULTS 
Mouse Vaccination and Challenge 
Vaccination-challenge studies were performed to determine whether the 
recombinant 31-kDa protein would stimulate a protective immune response. The 
first vaccination-challenge study was inconclusive due to death of all the control 
mice injected with mucin only (Table 2). However, mice immunized with the 
recombinant 31-kDa protein were protected against challenge. In the second study 
the mucin controls survived. The LD50 of H. somnus for mice in the unvaccinated 
group was 1.26x10^. LD50 of H. somnus for mice immunized with E. çoli with the 
vector plasmid only and with the recombinant expressing the 31-kDa antigen were 
3.17x10® and 1.59x10' respectively (Table 3), The relative potency (RP) of the 
recombinant was determined to be 5 when compared with the E. çoli containing 
the vector plasmid only. 
Diagnostic Test 
Monoclonal antibodies were initially generated against a crude membrane 
fraction of recombinant HSI109 producing the 31-kDa antigen. The membrane 
fraction from the recombinant was used as an immunogen because it contained a 
relatively high amount of the 31-kDa protein as determined on SDS-PAGE (data not 
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Table 2. Survivors in 1st Vaccination-Challenge." 
Log Dilution Unvaccinated E. coli 31-kDa Mucin 


















" Vaccination on day 1, day 14 and challenged on day 28. 
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Table 3. Survivors in Second Vaccination-Challenge" 
Log Dilution Unvaccinated E. gdi 31-kDa Mucin 
of Challenge Controls Vector only Bacterin Controls 
-1 0/10 4/10 6/10 
-2 0/10 5/10 8/10 
-3 0/10 8/10 10/10 
-4 5/10 10/10 10/10 
-5 8/10 10/10 10/10 
-6 10/10 10/10 10/10 
-7 10/10 10/10 10/10 
-8 10/10 10/10 10/10 
No challenge 5/5 
° Vaccination on day 1, day 14 and day 28 and challenged on day 42. 
LD50 unvaccinated: 1.26x10'^  
LD50 E. coli with vector only: 3.17x10® 
LD50 31-kDa bacterin: 1.59x10' 
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shown). Four monoclonal antibodies against the membrane fraction of the 
recombinant HSI109 reacted strongly and specifically with the 31-kDa protein of H. 
somnus on Western blots. But these antibodies did not react with H. somnus in 
lung tissue sections using immunohistochemical staining (Table 4). Attempts to 
improve the reaction by incubating the sections with glycine phosphate buffer as a 
formalin quencher, or Triton X-100 to open up bacterial cells prior to 
immunohistochemical staining did not improve the staining reaction. 
To help determine whether formalin treatment has an adverse effect on the 
immunohistochemical staining reaction, smears of agar-grown H. somnus 8025 
were prepared on glass slides. The monoclonal antibodies reacted with the 
organisms when the slides were heat-fixed but not when they were fixed with 
formalin. One possibility for the failure of these monoclonal antibodies to react with 
H. somnus in lung tissue sections was a potential for modification of epitopes by 
various chemicals (especially formalin) during the tissue fixation processing 
procedure. 
In an attempt to determine whether formalin-treatment was the problem, 
monoclonal and polyclonal antibodies were generated against formalin-killed 
recombinant HSI109 and screened on ELISA with formalin-killed H. somnus as an 
antigen. The purpose for generating and screening antibodies against a formalin-
treated antigen was to obtain antibodies recognizing formalin-modified or formalin-
resistant epitopes in the 31-kDa protein. Six monoclonal antibodies generated 
against the formalin-killed recombinant reacted strongly on ELISA when formalin-
Table.4. Immunoreactivities of mouse monoclonal and polyclonal antibodies in serological tests." 
Antibodies Serological tests " 





lung tissue bacterial smears 
heat-fixed formalin-fixed 
MAbm " + - + - + -
MAbf " - + ND - ND ND 
PAbf " - + ND - + + + 
PAbfH + + + + ND ND 
" Monoclonal antibody raised against crude membrane fraction of the recombinant. 
^ Monoclonal antibody raised against formalin-killed recombinant. 
" Polyclonal antibody raised against formalin-killed recombinant. 
Polyclonal antibody raised against formalin-killed H. somnus. 
" H. somnus was used as an antigen in all the serological tests. 
Table.5. Immunoreactivities of Guinea pig polyclonal sera in serological tests. 
Immunogen Serological Tests " 
ELISA Western blot IHC 
Staining Formalin-killed TritonX-100 extract General 31-kDa 
Formalin-killed H. somnus + + + + + + + + + + 
Recombinant: 
Formalin-killed - + + . + -
UV-killed - + + + + -
Heat-killed + + + + + + + 
" H. somnus was used as an antigen in all the serological tests. 
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killed H. somnus was used as an antigen (Table 4). However, these antibodies 
failed to detect H. somnus in lung tissue sections. Triton X-100 treatment did not 
improve the results. 
Mouse polyclonal serum generated against formalin-killed recombinant 
HSI109 bound strongly to agar-grown H. somnus on glass slides whether the 
slides were heat- or formalin-fixed. Triton X-100 treatment prior to 
immunohistochemical staining of the agar-grown bacteria increased the resolution 
of the reaction with the polyclonal serum. 
Polyclonal mouse serum against formalin-killed H. somnus reacted well with 
H. somnus in all the serologic tests, i.e., ELISA, Western blot and 
immunohistochemical staining (Table 4). This serum had some crossreactivities 
and background problems in the immunohistochemical staining procedure and was 
not tested further. It was used initially as a positive control for the 
immunohistochemical stain. 
Polyclonal Guinea pig sera were generated against formalin-killed H. somnus 
and three different preparations of recombinant HSI109, i.e., formalin-, UV-, or heat-
killed. Guinea pigs were chosen to generate polyclonal serum because Guinea pigs 
can provide a larger amount of serum than mice. Also, unlike rabbits, they usually 
do not have antibody to the Pasteurella species which interferes with the use of 
serum as a diagnostic reagent for bovine respiratory disease. The recombinants 
were killed in different ways to determine whether methods of antigen preparation 
might affect the character of the humoral immune response in Guinea pigs (Table 
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5). Polyclonal Guinea pig sera against formalin-killed H. somnus and the heat-killed 
recombinant showed a moderate reaction in ELISA using plates coated with 
formalin-killed H. somnus. Sera against the formalin- or UV-killed recombinant 
Immunogens had a low level of reactivity. On Western blot, the strongest reaction 
to the 31-kDa protein of H. somnus was given by sera against UV-killed 
recombinant HSI109 (data not shown). Guinea pig sera against formalin-killed H. 
somnus and heat-killed recombinant HSI109 reacted strongly with H. somnus in 
immunohistochemical staining (Fig. 1). These Guinea pig sera were further tested 
for their reactivities to H. somnus in other lung tissue sections known to be infected 
with either JH. somnus. P. multocida. or P. haemolytica. Out of twelve lungs tested, 
these polyclonal sera detected H. somnus from eight. Bacteria were not detected 
on histopathologic examination in those lung tissue sections in which these 
polyclonal sera did not detect H. somnus. Variable crossreactivities to P. 
haemolytica and P. multocida were observed. However, in some tissues from 
which a heavy growth of P. haemolytica or P. multocida was recovered, the 
polyclonal sera did not detect any bacteria (Fig. 2) 
Fig. 1. Immunoliistochemical staining of H. somnus in bovine lung tissue (x400). 
Polyclonal Guinea pig sera against heat-killed recombinant detected H. 
somnus strongly characterized by brown staining (A). B. Negative serum 
control. 
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Fig. 2. Immunohistochemical staining of bovine lung tissue from which P. 
haemolytica was recovered (x400). Although microcolonies were present, 




Our previous study indicated that the 31-kDa antigen of Haemophilus 
somnus may be an important protective antigen (37). The 31-kDa antigen 
consistently reacted with convalescent sera from cattle that had survived H. 
somnus challenge as well as with sera from cattle vaccinated with a commercial 
bacterin and an experimental bacterin. A comparison of the deduced amino acid 
sequence of the 31-kDa antigen also indicated 25.6-41.8% homology with the 
carboxy-terminal ends of virulence-associated proteins of other bacteria (37). 
However, the function of the 31-kDa antigen and its potential role as a virulence 
factor or protective antigen in cattle has not been identified. In this study, mice 
were protected by vaccination with the recombinant expressing the 31-kDa antigen 
of H. somnus. However, a relatively high degree of protection was also provided 
by E. coli alone. It was not surprising because E. coli used as a host for the pUC 
19 plasmid in this study was a rough mutant (12). It is assumed that at least a 
portion of the core region of the LPS is exposed. It is possible that antibodies 
directed against core epitopes of LPS might provide significant protection against 
endotoxemia. The role of endotoxemia in the mouse challenge model used in this 
study has not been determined, but it probably plays a major role in the death of 
the mice. In this study, an additional protective effect was noted with the 
recombinant 31-kDa protein. Further study is required to conclude protective role 
of the 31-kDa antigen in H. somnus infection in cattle. 
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The failure of monoclonal antibodies against the crude membrane fraction 
(MAbm) and the formalin-killed recombinant HSU 09 (MAbf) to detect H. somnus on 
IHC staining brought into question in the conformation and location of the 31-kDa 
antigen in H. somnus. Since monoclonal antibodies (MAbm) failed to detect 
formalin-fixed H. somnus smears previously, we postulated that the formalin-fixation 
procedure might alter the epitopes of the antigen so that it no longer reacted with 
monoclonal antibodies. However, our data with monoclonal antibodies against the 
formalin-killed recombinant and polyclonal mouse and Guinea pig sera suggests 
the situation may be more complicated. It seems that using formalin or UV-
irradiation in antigen preparation limits availability of the the 31-kDa antigen of the 
recombinant to the immune system as well as altering conformation of the 31-kDa 
antigen during the fixation procedure of lung tissue sections. It is also possible 
that different epitopes are exposed in the various serological tests. 
The location of the 31-kDa protein in H. somnus and the recombinant is not 
clear. In our previous study, the carboxy-terminal ends of the 31-kDa protein of H. 
somnus shared homology with those of outer membrane protein A (OmpA) of E. 
coll (37). The carboxy-terminal end of OmpA (178-325) was reported to be located 
in the periplasmic layer (4). It is not known whether this sequence homology 
indicates structural similarity between OmpA of E. çoli and the 31-kDa protein of H. 
somnus. 
Polyclonal Guinea pig sera directed against formalin-killed H. somnus and 
the heat-killed recombinant have potential for use in diagnosis of respiratory 
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disease by H. somnus. Crossreactivities of poiyclonal antiserum to other 
respiratory pathogen such as JP. haemoiytica and P. multocida were observed in 
other serological tests including the agglutination test and complement fixation test 
(10, 32). The specificity of the staining reaction was difficult to evaluate because 
the lung tissues were from naturally infected cattle. Some lung tissue sections from 
which P. haemoiytica or P. multocida were recovered also stained with polyclonal 
Guinea pig sera. H. somnus was not recovered from these tissues. In some 
tissues from which a heavy growth of P. haemoiytica or P. multocida was 
recovered, the polyclonal sera did not detect any bacteria. It is possible that there 
might have been H. somnus present that was not recovered because of 
overgrowth by Pasteurella species. The specificity of the antibodies needs to be 
evaluated using lung tissues of cattle challenged with single etiologic agents. 
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GENERAL SUMMARY AND DISCUSSION 
There have been inconsistent reports concerning the efficacy of killed 
bacterins against diseases caused by Haemophilus somnus (44, 46, 71, 72, 92, 97, 
107,123). These inconsistent results could be attributed to different methods In 
the route and the dose of challenge, evaluation of bacterin efficacy, administration 
of immunogen and the immunization schedule applied in vaccination studies. 
Various conditions in weather, management and concomitant infection also add 
difficulties in interpreting vaccination results (46, 71, 97). Failure to induce specific 
immunoglobulin isotypçs and immunoglobulins specific for protective antigens were 
suggested to be causes for some of the failure of H. somnus bacterins to provide 
protection against H. somnus. Several studies indicated that a subunit vaccine 
might provide more protection by focusing the host immune response on 
protective antigens thereby preventing unnecessary or even detrimental responses 
to other bacterial components. Convalescent-phase bovine sera were used in 
attempts to determine which components of the bacterium are most important in 
the immune response (21, 39, 40). The assumption was that antigens recognized 
by antisera from cattle recovered from H. somnus respiratory disease would be 
possible candidates for protective antigens. Consistent immunoreactivities were 
observed with the 40-, 76-, and the 78-kDa antigens of H. somnus in several 
reports (21, 40). The 40-kDa antigen was reported to provide passive protection 
and has been recently shown to be a lipoprotein (21, 108). Antibodies against the 
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78-kDa antigen failed to endow protection and this was suggested to be due to the 
lack of an lgG2 response (39). Our studies indicated that the 31-kDa antigen was 
also consistently immunoreactive although it was not an immunodominant protein. 
To evaluate protective role of immunoreactive proteins, a genomic library of 
H. somnus 8025 DNA was constructed in plasmid pUC19. Recombinants 
expressing immunoreactive proteins were detected by colony blotting using 
hyperimmune rabbit sera against killed H. somnus. On Western blots using bovine 
serum against H. somnus. recombinants expressed proteins ranging from 18 to 
200 kDa. There were 11 recombinants expressing a 31-kDa protein. To determine 
the protective ability of the recombinant expressing the 31-kDa protein of H. 
somnus. mice were vaccinated 2-3 times with the heat-killed recombinant, followed 
by a intraperitoneal challenge with H. somnus 156A. Vaccination with the 
recombinant provided protection compared to E. goli with vector only (relative 
potency of HSI109 versus E. coli DH5a(pUC19) = 5), The relatively high degree of 
protection provided by E. coli alone was somewhat expected. E. goli used in this 
study is a rough mutant in which the core region of LPS is exposed. It is possible 
antibodies against the core region of LPS might provide some protection from 
endotoxemia, resulting in an increase in survival rate in mice. Another possibility is 
that mice were challenged too soon after the last immunization so that the immune 
response stimulated nonspecifically by LPS in the E. soli was still active. Although 
vaccination with the 31-kDa antigen-expressing E. goli recombinant provided some 
protection in mice, it is difficult to predict the efficacy of this material in cattle. 
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Cattle are generally vaccinated and challenged by a different route (44, 107, 123) 
and it is difficult to extrapolate from data obtained with mice. Further study is 
required to conclude whether immunization with the 31-kDa antigen of JH. somnus 
can provide protection against disease in cattle. In addition, one needs to 
determine the optimum means of inactivating E. coli if the recombinant is used as 
an immunogen. If H. somnus is used as either a whole-cell bacterin or as a source 
for a subcellular fraction, one needs to recognize the necessity to evaluate the 
presentation of antigens and how this can be manipulated to optimize the immune 
response. In addition, future studies with the recombinant 31-kDa protein should 
attempt to measure the lgG2 titer before and after vaccination and challenge 
because the lgG2 titer was suggested to be important in protection (39, 121). The 
whole area of how cattle respond immunologically to the multiplicity of H. somnus 
antigens needs to be explored before logical decisions can be made concerning 
the best materials and methods for protecting cattle against disease. 
An additional area that could be explored in the immunization of cattle is the 
potential for utilizing a rough core mutant as an integral portion of any vaccine. 
Rough core mutants of E. goli and other Gram-negative bacteria are finding 
increasing use for protection of animals against the effects of endotoxemia (28, 
112). Endotoxemia is thought to be an important factor in some of the diseases 
caused by H. somnus. Protection against respiratory diseases in cattle may be 
enhanced by antibody specific for endotoxin. However, one problem with these 
rough core vaccines is a relatively short duration of immunity (32). This tends to 
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limit their usefulness for certain diseases unless one is willing to repeatedly 
immunize susceptible animals. H. somnus and other bovine respiratory-tract 
pathogens often cause serious infections in conjunction with shipping. This 
presents a relatively narrow window of vulnerability of approximately one month 
following shipping. Cattle immunized within a month prior to shipping would be the 
most likely to benefit from antibody against endotoxin. A rough core mutant has 
the potential to provide significant advantages when combined with specific 
recombinant antigens or subcellular fractions. Such an immunizing product may 
be much more efficacious for the prevention of respiratory diseases. Our data in 
mice indicating that E. soli containing only the vector plasmid provided a strong 
immune response gives evidence that such combined immunizing products should 
be explored. 
According to sequencing and deletion mutation, immunoreactivity was 
located in carboxy-terminal ends of the 31-kDa antigen. The carboxy-terminal ends 
shared homology with outer membrane protein A of E. coli (7), Salmonella 
tvphimurium (37), and Shigella dvsenteriae (11), with P6 of Haemophilus influenzae 
(80) and with PHI of Neisseria gonorrhoeae (42). Although these proteins were 
implicated as protective antigens or virulence factors, it can not be concluded at 
this time that this homology indicates functional similarities. 
Another characteristic of the recombinants expressing the 31-kDa protein 
was strong iS-hemolysis of bovine erythrocytes. This complete hemolysis was 
unexpected because H. somnus 8025 from which the 31-kDa antigen gene 
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originated produced incomplete hemolysis. It was theorized that the stronger 
hemolysis in the recombinant is probably due to high expression of the gene. 
According to Southern blotting, the 31-kDa antigen gene is present as a single 
copy in H. somnus 8025. Deletion mutation suggested that hemolytic activity was 
present in the amino-terminal end of protein. However, the deduced amino acid 
sequences from DNA sequence did not have significant homology with other 
known hemolysins. The 31-kDa antigen might need to be transported to the 
surface to exert its function and the transporter protein may not function in H. 
somnus. We have been unable to purify the 31-kDa protein in active form and it is 
possible that the observed hemolysis could be merely the result of overexpression 
of a foreign protein in E. coli. The 31-kDa protein also could be a regulatory 
protein that activates a hidden hemolysin gene which might be present in E. coN. 
The role of hemolysins in the pathogenesis of H. somnus disease is not 
clear. H. somnus isolates from the reproductive tract of healthy cattle had a wide 
range of hemolytic activities from non-hemolytic to B-hemolytic (49). There seemed 
to be no correlation between hemolytic activity and virulence. Cytotoxic or 
inhibitory effects on cells of the immune system have been reported with many 
other hemolysins (61, 62, 90). The cytotoxic effect of H. somnus on bovine 
alveolar macrophages and bovine endothelial cells has been reported (64, 109). 
However, the responsible factor(s) was unidentified. 
There is a great need for a diagnostic reagent for H. somnus because of the 
difficulty experienced in recovering the organism from infected cattle. These 
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difficulties are due to the relatively fastidious nature of the organism and its slow 
growth which allows it to be overgrown by contaminating bacteria (23, 117). 
Widespread use of antibiotic therapy also causes difficulties in diagnosis by 
Interfering with recovery of the organism from tissues of diseased animals (10, 46). 
Immunohistochemical staining may be useful as a diagnostic test because this test 
is frequently used for diagnosing respiratory diseases. This method is also simple 
and does not require cultivation of pathogens. Since polyclonal serum showed 
crossreactivities to other bacteria in other serological tests (16, 31, 78, 99), we 
generated monoclonal antibodies against the 31-kDa antigen to avoid 
crossreactivities. Monoclonal mouse antibodies against a crude membrane 
preparation or the formalin-killed recombinant gave strong reactions on ELISA and 
Western blot to H. somnus. but did not detect H. somnus in immunohistochemical 
staining of lung tissue sections. Mouse polyclonal antibodies against the formalin-
killed recombinant did not detect H. somnus in lung tissue either. However, mouse 
polyclonal antibodies against formalin-killed H. somnus provided good detection of 
H. somnus in immunohistochemical staining. Formalin may not be the only factor 
involved in possible epitope modification but, whatever the sequence of events, the 
31-kDa antigen seems to be very vulnerable. Generation and testing of Guinea pig 
sera against various preparations of the recombinant revealed that using formalin 
or UV-irradiation in antigen preparation may limit the availability of the the 31-kDa 
antigen of the recombinant to the immune system. When combined with a 
possible alteration in conformation of the 31-kDa antigen during the fixation 
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procedure of lung tissue sections, one can readily see that a monoclonal antibody 
may have deficiencies as a diagnostic reagent. We have demonstrated that the 
results can also vary greatly depending on the type of diagnostic test chosen. It is 
very likely that different epitopes are exposed in the various serological tests, thus 
giving rise to the differences in sensitivity. 
Polyclonal Guinea pig sera against a heat-killed recombinant and formalin-
killed H. somnus readily detected H. somnus in immunohistochemical staining. 
However, variable crossreactivities were observed with Pasteurella species in 
naturally infected lungs. The specificity of the antibodies needs to be evaluated 
using lung tissues of cattle challenged with single etiologic agents. It might be 
necessary to adsorb polyclonal antiserum against E. coli to reduce the 
crossreactivity to other gram-negative bacteria. However, the polyclonal Guinea 
pig serum has considerable promise in a diagnostic test. Work should continue to 
further develop it as a reagent. 
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